United States v. Monsanto Co.; Proposed Final Judgment and Competitive Impact Statement, 33336-33360 [07-2897]
Download as PDF
33336
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
DEPARTMENT OF JUSTICE
Antitrust Division
rwilkins on PROD1PC63 with NOTICES2
United States v. Monsanto Co.;
Proposed Final Judgment and
Competitive Impact Statement
Notice is hereby given pursuant to the
Antitrust Procedures and Penalties Act,
15 U.S.C. 16(b)–(h), that a Complaint,
proposed Final Judgment, Hold Separate
and Preservation of Assets Stipulation
and Order, and Competitive Impact
Statement have been filed with the
United States District Court for the
District of Columbia in United States v.
Monsanto Co., Civ. Action No.
1:07CV00992. On May 31, 2007, the
United States filed a Complaint alleging
that the proposed acquisition by
Monsanto Company (‘‘Monsanto’’) of
Delta and Pine Land Company (‘‘DPL’’)
would violate Section 7 of the Clayton
Act, 15 U.S.C. 18. The Complaint alleges
that the acquisition would substantially
reduce competition for the
development, breeding, and sale of
traited cottonseed in the MidSouth
(Mississippi, Arkansas, Louisiana,
Missouri, and Tennessee) and Southeast
(Alabama, Georgia, Florida, South
Carolina, North Carolina, and Virginia)
United States. Specifically, the
Complaint alleges that Monsanto’s
acquisition of Delta and Pine Land
would enhance Monsanto’s ability and
incentive to raise traited cottonseed
prices and eliminate Delta and Pine
Land as a partner independent of
Monsanto for competing trait
developers. The proposed Final
Judgment, lodged at the same time as
the Complaint, requires the parties to
divest (1) Monsanto’s Stoneville
Pedigreed Seed Company; (2) other
Monsanto cotton breeding assets; (3)
specified lines of Delta and Pine Land
cottonseed to the acquirer of the
Stoneville assets; (4) and specified lines
of Delta and Pine Land cottonseed
containing the VipCot transgenic trait to
Syngenta AG. It also requires Monsanto
to modify certain licenses. A
Competitive Impact Statement filed by
the United States describes the
Complaint, the proposed Final
Judgment, and the remedies available to
private litigants who may have been
injured by the alleged violation.
Copies of the Complaint, proposed
Final Judgment, Hold Separate and
Preservation of Assets Stipulation and
Order, and Competitive Impact
Statement are available for inspection at
the Department of Justice, Antitrust
Division, 325 7th Street, NW., Suite 215,
Washington, DC 20530 (202–514–2481),
on the Internet at https://www.usdoj.gov/
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
atr, and at the Office of the Clerk of the
United States District Court for the
District of Columbia. Copies of these
materials may be obtained from the
Antitrust Division upon request and
payment of the copying fee.
Public comment is invited within
sixty (60) days of the date of this notice.
Such comments, and responses thereto,
will be published in the Federal
Register and filed with the Court.
Comments should be directed to Donna
N. Kooperstein, Chief, Transportation,
Energy & Agriculture Section, Antitrust
Division, Department of Justice, 325 7th
Street, NW., Suite 500, Washington, DC
20530 (202–307–6349).
J. Robert Kramer II,
Director of Operations, Antitrust Division.
United States District Court for the
District of Columbia
United States of America, Department
of Justice, Antitrust Division, 325 7th
Street, NW., Suite 500, Washington, DC
20530, Plaintiff, v. Monsanto Company,
800 North Lindbergh Boulevard, St.
Louis, MO 63167, and Delta and Pine
Land Company, 1 Cotton Row, Scott,
MS 38772, Defendants
Civil Case No.:
Case: 1:07–cv–00992.
Assigned To: Urbina, Ricardo M.
Assign. Date: 5/31/2007.
Description: Antitrust.
Complaint
The United States of America, acting
under the direction of the Attorney
General of the United States, brings this
civil action to enjoin the merger of
defendants Monsanto Company
(‘‘Monsanto’’) and Delta and Pine Land
Company (‘‘DPL’’) and allege as follows:
1. In 2006, cottonseed was planted on
more than 15 million acres in the
United States and generated more than
$5 billion in annual revenues for United
States farmers. Cotton is grown across
the Southern United States from
Virginia, the Carolinas, Georgia, and
Florida on the East Coast to California
on the West Coast.
2. Farmers grow substantially all of
this important crop from cottonseed that
has been enhanced through the
introduction of biotechnology traits
(‘‘traited cottonseed’’). Traited
cottonseed results from combining
cottonseed stock that has attractive
growing characteristics (such as
producing a high yield of cotton per
acre) with performance traits foreign to
cotton that are inserted through genetic
engineering.
3. Monsanto is the largest producer
and supplier of biotechnology traits sold
in cottonseed in the United States, with
PO 00000
Frm 00002
Fmt 4701
Sfmt 4703
over 96% of United States traited
cottonseed containing Monsanto traits.
Monsanto is also one of the largest
sellers of traited cottonseed in the
United States, primarily through its
Stoneville Pedigreed Seed Company
(‘‘Stoneville’’).
4. DPL is the largest producer of
cottonseed in the United States. DPL is
the leading seller in the MidSouth
(Mississippi, Arkansas, Louisiana,
Missouri, and Tennessee), where DPL
sells 79% of all traited cottonseed, and
the Southeast (Alabama, Georgia,
Florida, South Carolina, North Carolina,
and Virginia), where DPL sells 87% of
all traited cottonseed.
5. In the 1980s, Monsanto partnered
with DPL to introduce cottonseed
containing Monsanto traits. DPL’s
experienced and knowledgeable cotton
breeders and large collection of highquality germplasm (the genetic material
of a cottonseed that gives the plant its
characteristics) provided Monsanto with
an unparalleled avenue through which
to commercialize and market its traits.
The combination of Monsanto traits and
DPL cottonseed has been highly
successful, particularly in the MidSouth
and Southeast, due to the performance
of DPL’s cottonseed and the value of
Monsanto’s biotechnology traits in those
regions.
6. Monsanto’s position as the
dominant supplier of traits used in
cottonseed was jeopardized in the early
2000s when DPL began to partner with
other biotechnology companies.
Through these partnerships, DPL’s
germplasm library and breeding
capabilities were available to alternative
trait developers, allowing them to work
toward introducing new traits in DPL
cottonseed that would compete with
Monsanto’s traits. DPL publicly stated
its intent to replace Monsanto traits in
its products and planned to launch
products with non-Monsanto traits as
early as the 2009 growing season, with
additional products to follow.
7. Spurred by this competitive threat
and recognizing the potential for a
successful pairing of DPL’s cottonseed
with competing traits, Monsanto
purchased Stoneville to position
Monsanto to compete vigorously with
DPL. Monsanto aggressively worked to
develop Stoneville’s germplasm and its
traited cottonseed sales and also
continued its efforts to develop
germplasm and expand traited
cottonseed sales through its Cotton
States business unit.
8. The proposed merger will
consolidate Monsanto’s and DPL’s
traited cottonseed sales, eliminating
competition between these firms in the
sale of cottonseed. DPL and Monsanto
E:\FR\FM\15JNN2.SGM
15JNN2
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
together would control over 95% of
sales in the important MidSouth and
Southeast regions, where harvested
cotton garners higher prices per bale,
and where cottonseed traits are most
valued by farmers. The proposed merger
will also eliminate DPL as a partner
independent of Monsanto for competing
trait developers, substantially delaying
or preventing the development and
introduction of cottonseed containing
non-Monsanto traits. Accordingly,
Monsanto’s merger with DPL would
substantially lessen competition in
violation of Section 7 of the Clayton
Act, 15 U.S.C. 18.
Jurisdiction and Venue
9. This action is filed by the United
States under Section 15 of the Clayton
Act, as amended, 15 U.S.C. 25, to
prevent and restrain Defendants from
violating Section 7 of the Clayton Act,
15 U.S.C. 18.
10. Monsanto and DPL are engaged in
interstate commerce and in activities
substantially affecting interstate
commerce. The Court has jurisdiction
over this action and the parties pursuant
to Sections 15 and 16 of the Clayton
Act, 15 U.S.C. 25, 26; and 28 U.S.C.
1331, 1337.
11. The Defendants have consented to
personal jurisdiction and venue in this
judicial district.
II. The Defendants
12. Defendant Monsanto is a Delaware
corporation, with its headquarters
located in St. Louis, Missouri. Monsanto
is a leading global provider of
agricultural products for farmers,
including seeds for cotton, soybeans,
and corn; traits that help farmers control
insects and weeds; and crop protection
chemicals such as the herbicide
Roundup, a branded version of the
chemical glyphosate. Monsanto had
total company revenues of more than
$7.3 billion in 2006.
13. Defendant DPL is a Delaware
corporation, with its headquarters
located in Scott, Mississippi. DPL is the
largest cottonseed producer in the
world. DPL’s sales in the United States
in 2006 exceeded $400 million.
III. Trade and Commerce
rwilkins on PROD1PC63 with NOTICES2
A. Affected Commerce
Cottonseed Varieties
14. Cottonseed varieties differ in their
performance, including the yield, the
strength and the length of the cotton
fibers, and the adaptability of the
cottonseed to specific weather
conditions and soil types. Varieties that
perform best in certain regions of the
country, such as the drier areas of the
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
Southwest (including West Texas,
Kansas, and Oklahoma) do not typically
perform well in other regions, such as
the MidSouth and the Southeast.
Farmers select cottonseed varieties that
have the best performance
characteristics for the area in which the
cottonseed will be planted, with the
primary focus on yield.
15. To be competitive, cottonseed
companies must continually work on
developing new and improved
cottonseed varieties through their
breeding programs. Cotton breeding is a
costly and time-consuming process in
which the cottonseed company selects
lines to breed together (or ‘‘cross’’),
plants the cottonseed produced from
that initial cross, and then selects the
best plants for further crossing to create
a variety with the desired
characteristics. In most cases, it takes
eight to ten years from the initial cross
until a new cottonseed variety is ready
for market.
16. The success of a cottonseed
company’s breeding program is
dependent on many factors, the most
important of which is the quantity and
quality of available breeding materials,
i.e. germplasm. A company with a large
collection of high quality, or elite,
germplasm has a competitive advantage
because the company has the ability to
identify the best genetic material and
use it in a wide variety of possible
crossing combinations, resulting in a
greater likelihood of developing a
successful variety.
17. DPL has the largest cotton
germplasm collection, with by far the
greatest track record of success in the
important MidSouth and Southeast
regions, and an extensive breeding
program for cottonseed. It has eight
research or breeding facilities in the
United States and five located elsewhere
in the world. It has more breeding
capabilities than any competitor and
over ninety years of germplasm
development.
Traits for Cottonseed
18. Historically, farmers grew cotton
from conventional cottonseed that
contained naturally occurring
characteristics. Cotton farming with
conventional cottonseed involved labor
intensive and costly herbicide and
insecticide spraying programs that
required multiple applications at very
specific times in the growing season.
Failure to spray or to correctly time the
applications could result in substantial
crop damage.
19. In the 1980s, Monsanto developed
a trait that could be inserted into cotton
plants to make plants resistant to certain
insects. It also developed an herbicide-
PO 00000
Frm 00003
Fmt 4701
Sfmt 4703
33337
tolerant trait that would make cotton
plants grown from cottonseed with the
trait resistant to certain herbicides
sprayed to kill weeds, allowing farmers
to spray herbicides less precisely
without killing the young plants.
20. To gain acceptance by farmers, the
traits had to be delivered in cottonseed
lines that performed well in the growing
area where the farmer was located. In
1988, Monsanto approached DPL to
develop and commercialize cottonseed
with the Monsanto insect-resistant and
herbicide-tolerant traits. DPL was then,
and still is, the market leader in
cottonseed, with what was considered
the best germplasm and the most
sought-after varieties.
21. The companies proceeded with
the development and commercialization
process, which involved inserting the
Monsanto trait into DPL germplasm,
evaluating plant lines grown from that
germplasm, and breeding promising
candidate plants to produce varieties
with desired characteristics. In 1996,
DPL began to sell the first cottonseed
with Monsanto’s initial insect-resistant
trait (marketed under the name
‘‘Bollgard’’), and, the following year, it
introduced a variety with Monsanto’s
initial herbicide-tolerant trait (marketed
under the name ‘‘Roundup Ready’’).
22. Farmers, particularly those in the
MidSouth and Southeast, quickly
adopted traited cottonseed because its
use significantly lowered overall
farming costs, increased yields, and
reduced the risk of crop loss. Today,
almost all cottonseed varieties planted
in the United States are traited, and, in
2006, over 96% of the traited cottonseed
sold in the United States contained
traits developed by Monsanto.
23. When farmers acquire traited
cottonseed, they pay a price per bag to
the seed distributor, who pays the seed
manufacturer for the seed, and a
separate license fee (commonly referred
to as the ‘‘technology fee’’) to the
developer of the trait. Typically, the
trait developer shares a portion of the
technology fee with the seed
manufacturer. The technology fee can
constitute as much as 80% of farmers’
total costs for a bag of traited
cottonseed.
DPL’s Trait Development With
Monsanto’s Competitors
24. Following Monsanto’s and DPL’s
successful introduction oftraited
cottonseed, they agreed in 1998 that
Monsanto would acquire DPL. The
Antitrust Division of the United States
Department of Justice investigated the
proposed transaction. In late 1999,
while the transaction was still under
review, Monsanto decided to abandon
E:\FR\FM\15JNN2.SGM
15JNN2
rwilkins on PROD1PC63 with NOTICES2
33338
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
the transaction. DPL thus remained an
independent company.
25. Despite ensuing litigation from the
companies’ failed attempt to merge, DPL
continued to develop and market
cottonseed varieties with Monsanto’s
traits. DPL also commenced a strategy to
replace (or ‘‘trade-out’’) the Monsanto
traits in DPL cottonseed with traits of
other companies. DPL believed that this
strategy would be profitable for DPL
because competing trait developers
would offer DPL a higher percentage of
the technology fee for traits than would
Monsanto. In DPL’s suit against
Monsanto for breach of the merger
agreement, DPL alleged significant
financial losses resulting from the delay
that the failed merger caused to DPL’s
efforts to develop traits with companies
other than Monsanto.
26. Pursuant to the trade-out strategy,
DPL has worked with several other
biotechnology companies, including
Dow AgroSciences, DuPont, Syngenta
Crop Protection AG and Bayer
CropScience, to develop and
commercialize cottonseed containing
the traits developed by these companies
that would compete with cottonseed
containing Monsanto’s traits. DPL is an
attractive partner that is well suited to
quickly introduce new trait technologies
due to the strength and breadth of its
germplasm base and breeding programs
as well as its technical service
capabilities, know-how, brand
recognition and market position.
27. DPL’s trait license with Monsanto
also makes DPL an attractive partner for
competing trait developers. Most
farmers in the United States buy
cottonseed containing traits that provide
both herbicide tolerance and insect
resistance. In the MidSouth and
Southeast United States, the vast
majority of farmers use both traits.
DPL’s trait licenses with Monsanto
allow DPL to offer competing trait
developers the ability to combine or
‘‘stack’’ their traits in DPL cottonseed
along with Monsanto traits. This
stacking right would allow, for example,
the developer of an insect-resistant trait
to bring that trait to market in
cottonseed that also contains a
Monsanto herbicide-tolerant trait (i.e.,
Roundup Ready or the more-recent
version, Roundup Ready Flex).
Monsanto’s trait licenses with most
other cottonseed companies, by
contrast, severely restrict the ability of
these companies to work with other trait
developers, with some of these licenses
prohibiting the stacking of cottonseed
containing Monsanto traits with another
company’s traits and others subjecting
the licensees to severe penalties if they
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
stack non-Monsanto traits with
Monsanto traits.
28. Even with the advantages that
partnering with DPL offers Monsanto’s
competing trait developers, the process
to develop, breed and commercialize
cotton varieties with traits typically
takes eight to twelve years and costs
over $40 million. The process often
requires thousands of attempts before
developing a traited cottonseed that
then can be used to breed commercial
varieties. In addition, extensive
regulatory approvals, both in the United
States and abroad, are required.
29. DPL’s trait-development work
with Monsanto’s competitors has
recently begun to show results. DPL’s
developmental work with Syngenta
resulted in a 2004 agreement to
commercialize cottonseed with
Syngenta’s VipCot insect-resistant traits.
DPL expects to begin marketing such
cottonseed as early as 2009. The DPL/
Syngenta agreement provides that DPL
will receive 70% of the net trait
technology fees earned through sales of
this product, compared with the 30%
that DPL earns pursuant to its Monsanto
agreement.
Monsanto’s Competitive Reaction to
DPL’s ‘‘Trade-Out’’ Plan
30. Monsanto recognized that its and
DPL’s ‘‘paths will continue to diverge’’
as DPL continues its strategy to replace
Monsanto traits in DPL cottonseed with
traits developed by Monsanto’s
competitors. Driven by the competitive
threat posed by DPL’s work with these
other companies, Monsanto set about
building its own cottonseed business.
31. In 2002, Monsanto began Cotton
States, through which Monsanto obtains
licenses on germplasm developed by
private breeders and universities, breeds
its traits into the germplasm, and outlicenses the resulting traited varieties to
sellers of cottonseed for sale under their
private labels.
32. In 2005, Monsanto repurchased
Stoneville, the second-largest traited
cottonseed company in the MidSouth
and Southeast United States. Monsanto
had previously owned Stoneville but
sold it in 1999 before abandoning its
attempt to acquire DPL. Upon
reacquiring Stoneville, Monsanto
immediately invested capital to improve
Stoneville’s competitive position.
33. Monsanto aggressively worked to
strengthen its cottonseed business by,
among other things, focusing on
advanced breeding techniques and
germplasm development and investing
in breeding facilities. Monsanto
predicted internally that these
investments would enable Monsanto to
increase its share of the cottonseed
PO 00000
Frm 00004
Fmt 4701
Sfmt 4703
business at the expense of DPL and
other companies.
B. Relevant Markets
34. Across regions such as the
MidSouth and Southeast, growing
conditions for cotton differ due to
weather conditions, soil type, and
varied demands for weed and insect
control. Fanners demand cottonseed
varieties that produce high yield for
their particular growing conditions.
Monsanto and DPL recognize this
demand and market cottonseed varieties
by region.
35. In many regions of the country,
including the MidSouth and Southeast,
farmers demand that cottonseed have
traits to provide insect resistance and
herbicide tolerance. Monsanto prices
traits by region.
36. Cotton fanners consider cotton the
most valuable crop for their land, and
the cost of the traited cottonseed
amounts to only a fraction of the total
cost of growing cotton. If there were a
small but significant increase in price of
traited cottonseed within regions such
as the MidSouth and Southeast, it is not
likely that farmers would switch to
other crops or switch purchases to
conventional (non-traited) cottonseed or
cottonseed varieties not well suited for
their regions in sufficient volumes to
make the price increase unprofitable.
The development, commercialization,
and sale of traited cottonseed
constitutes a line of commerce or
product market, and the MidSouth and
Southeast United States are sections of
the country or geographic markets,
within the meaning of Section 7 of the
Clayton Act.
IV. Anticompetitive Effects
A. Concentration
37. DPL is the largest firm in the
traited cottonseed market in the United
States. It is even more dominant in the
MidSouth United States market, with
79% of the traited cottonseed sales, and
the Southeast United States market,
with over 87% of the traited cottonseed
sales.
38. Monsanto is the second-largest
traited cottonseed company in the
MidSouth and Southeast United States
markets, with 17% of sales in the
MidSouth United States market and 8%
of sales in the Southeast United States
market.
39. After the merger, Monsanto would
account for more than 95% of sales of
traited cottonseed in the MidSouth
United States market and 95% of sales
in the Southeast United States market.
40. Using a measure of market
concentration called the Herfindahl-
E:\FR\FM\15JNN2.SGM
15JNN2
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
Hirschman Index (‘‘HHI’’), explained in
Appendix A, Monsanto’s merger with
DPL would result in a post-merger HHI
of 9110 in the MidSouth United States
market, with an increase of 331O, and
a post-merger HHI of 9184 in the
Southeast United States, with an
increase of 1489.
a. Competition in the market for the
development, production, and sale of
traited cottonseed in the MidSouth and
Southeast United States would be
substantially lessened; and
b. Cotton farmers will suffer harm as
a result of fewer choices and higher
prices for traited cottonseed.
B. Effect of Transaction
VII. Request for Relief
Plaintiff requests that this Court
adjudicate and decree as follows:
1. That Monsanto’s proposed merger
with DPL would violate Section 7 of the
Clayton Act, as amended, 15 U.S.C. 18;
2. That Monsanto and DPL be
permanently enjoined from carrying out
their proposed merger, or from entering
into or carrying out any agreement,
understanding, or plan, the effect of
which would be to combine the
businesses or assets of Monsanto and
DPL;
3. That Plaintiff be awarded the costs
of this action; and
4. Such other relief as the Court may
deem just and proper.
41. The merger will eliminate
competition between DPL and
Monsanto for the development,
breeding, and sale of traited cottonseed.
As a result, farmers likely will have
fewer choices of, and face higher prices
for, traited cottonseed.
42. The merger will also eliminate
DPL as a partner independent of
Monsanto for developers of traits that
would compete against Monsanto. DPL’s
current efforts to develop and
commercialize cottonseed with
Syngenta’s VipCot insect-resistant
technology, which would be
competitive with Monsanto’s Bollgard
and more-recent Bongard II traits, will
be substantially delayed or prevented.
Further, the merger will likely delay if
not deter efforts to develop other traits
that would compete with Monsanto
traits and that would provide benefits to
United States cotton farmers, including
other insect-resistant traits, herbicidetolerant traits, and potentially other
cottonseed traits. As a result, farmers
likely will have fewer choices of, and
face higher prices for, traited
cottonseed.
43. Entry into the traited cottonseed
business requires the assets and
expertise both to breed high-performing
varieties of cottonseed and to develop or
access herbicide-tolerant and insectresistant traits to breed into the
cottonseed. Each of those steps requires
many years and the investment of tens
of millions of dollars.
44. Entry into the traited cottonseed
business would not be timely, likely, or
sufficient in its magnitude, character,
and scope to deter or counteract an
anticompetitive increase in the price of
traited cottonseed by the merged
Monsanto or DPL.
Dated: May 31, 2007.
Respectfully submitted,
For Plaintiff United States
Thomas O. Barnett,
Assistant Attorney General.
David L. Meyer,
Deputy Assistant Attorney General.
J. Robert Kramer II,
Director of Operations.
Donna N. Kooperstein,
Chief, Transportation, Energy & Agriculture
Section.
William H. Stallings,
Assistant Chief, Transportation, Energy &
Agriculture Section.
Jill A. Ptacek (WA Bar #18756)
Angela L. Hughes (DC Bar #303420)
J. Richard Doidge (MA Bar #600158)
Michael D. Billiel (DC Bar #394377)
David A. Blotner (WI Bar #1008674)
Ian R. Conner (V A Bar #65349)
John W. Elias (CA Bar #244620)
Tracy L. Fisher (MN Bar #315837)
Mark J. Niefer (DC Bar #470370)
Sarah L. Wagner (TX Bar #24013700)
Trial Attorneys, U.S. Department of Justice,
Antitrust Division, Transportation, Energy &
Agriculture Section, 325 7th Street, NW.,
Suite 500, Washington, DC 20004 Telephone:
(202) 307–6607, Facsimile: (202) 307–2784.
VI. Violation Alleged
Appendix A—Definition of HHI
45. The effect of Monsanto’s merger
with DPL may be substantially to lessen
competition in the market for the
development, production, and sale of
traited cottonseed in violation of
Section 7 of the Clayton Act. Unless
restrained, the transaction would likely
have the following effects, among
others:
‘‘HHI’’ means the Herfindahl-Hirschman
Index, a commonly accepted measure of
market concentration. It is calculated by
squaring the market share of each firm
competing in the market and then summing
the resulting numbers. For example, for a
market consisting of four firms with shares of
30, 30, 20, and 20 percent, the HHI is 2,600
(302 + 302 +202 + 202 = 2,600). (Note:
Throughout the Complaint, market share
rwilkins on PROD1PC63 with NOTICES2
V. Entry
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
PO 00000
Frm 00005
Fmt 4701
Sfmt 4703
33339
percentages have been rounded to the nearest
whole number, but HHIs have been estimated
using unrounded percentages in order to
accurately reflect the concentration of the
various markets.) The HHI takes into account
the relative size distribution of the firms in
a market and approaches zero when a market
consists of a large number of small firms. The
HHI increases both as the number of firms in
the market decreases and as the disparity in
size between those firms increases.
Markets in which the HHI is between 1,000
and 1,800 points are considered to be
moderately concentrated, and those in which
the HHI is in excess of 1,800 points are
considered to be highly concentrated. See
Horizontal Merger Guidelines 1.51 (revised
Apr. 8, 1997). Transactions that increase the
HHI by more than 100 points in concentrated
markets presumptively raise antitrust
concerns under the guidelines issued by the
U.S. Department of Justice and Federal Trade
Commission. See id.
United States District Court for the
District of Columbia
United States of America, Plaintiff,
Monsanto Company and Delta and Pine
Land Company, Defendants.
Case: 1:07–cv–00992 Assigned To:
Urbina, Ricardo M. Assign Date: 5/31/
2007 Description: Antitrust.
Proposed Final Judgment
Whereas, Plaintiff United States of
America filed its Complaint on May 31,
2007, Plaintiff and Defendants,
Monsanto Company (‘‘Monsanto’’) and
Delta and Pine Land Company (‘‘DPL’’),
by their respective attorneys, have
consented to the entry of this Final
Judgment without trial or adjudication
of any issue of fact or law, and without
this Final Judgment constituting any
evidence against or admission by any
party regarding any issue of fact or law;
And whereas, Defendants agree to be
bound by the provisions of this Final
Judgment pending its approval by the
Court;
And whereas, the essence of this Final
Judgment is the prompt and certain
divestiture of certain rights and assets
and alterations of certain existing
license terms by Defendants to assure
that competition is not substantially
lessened;
And whereas, Plaintiff requires
Defendants to make certain divestitures
and alter certain existing license terms
for the purpose of remedying the loss of
competition alleged in the Complaint;
And whereas, Defendants have
represented to Plaintiff that the
divestitures and license term alterations
required below can and shall be made
and that Defendants shall later raise no
claim of hardship or difficulty as
grounds for asking the Court to modify
any of the divestiture or license
alteration provisions contained below;
E:\FR\FM\15JNN2.SGM
15JNN2
33340
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
Now therefore, before any testimony
is taken, without trial or adjudication of
any issue of fact or law, and upon
consent of the parties, it is ordered,
adjudged and decreed:
I. Jurisdiction
This Court has jurisdiction over the
subject matter of and each of the parties
to this action. The Complaint states a
claim upon which relief may be granted
against Defendants under Section 7 of
the Clayton Act, 15 U.S.C. 18.
rwilkins on PROD1PC63 with NOTICES2
II. Definitions
As used in this Final Judgment:
A. ‘‘Acquirer of the Enhanced
Stoneville Assets’’ means the entity or
entities to whom Defendant Monsanto
divests the Enhanced Stoneville Assets.
B. ‘‘Cotton States’’ means Defendant
Monsanto’s cotton variety licensing
business pursuant to which Defendant
Monsanto licenses other cottonseed
companies to produce or sell Defendant
Monsanto’s own cotton varieties, cotton
varieties Defendant Monsanto inlicenses from other breeders, or cotton
varieties Defendant Monsanto produces
from such varieties.
C. ‘‘DPL’’ means Defendant Delta and
Pine Land Company, a Delaware
corporation with its headquarters in
Scott, Mississippi, its successors and
assigns, and its subsidiaries, divisions,
groups, affiliates, interests in
partnerships and joint ventures, and
their directors, officers, managers,
agents, and employees.
D. ‘‘DPL Acquirer’’ means the entity
to whom Defendant Monsanto divests
Defendant DPL.
E. ‘‘Monsanto’’ means Defendant
Monsanto Company, a Delaware
corporation with its headquarters in St.
Louis, Missouri, its successors and
assigns, and its subsidiaries, divisions,
groups, affiliates, partnerships and joint
ventures, and their directors, officers,
managers, agents, and employees.
F. ‘‘Stoneville’’ means all assets used
exclusively or primarily in, or to
support, the U.S. business of Stoneville
Pedigreed Seed Company, including,
but not limited to the assets described
in Schedule A.
G. ‘‘Enhanced Stoneville Assets’’
means Stoneville and the additional
assets, properties, and rights listed in
Schedule B.
H. ‘‘Syngenta’’ means Syngenta Crop
Protection AG, a Swiss corporation with
its headquarters in Basel, Switzerland,
its successors and assigns, and its
subsidiaries, divisions, groups,
affiliates, partnerships and joint
ventures, and their directors, officers,
managers, agents, and employees.
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
I. ‘‘Vip Cot Assets’’ means the assets,
properties, and rights listed in Schedule
C.
III. Applicability
A. This Final Judgment applies to
Defendants Monsanto and DPL, as
defined above, and all other persons in
active concert or participation with any
of them who receive actual notice of this
Final Judgment by personal service or
otherwise.
B. If, prior to complying with Sections
IV and V of this Final Judgment,
Defendants sell or otherwise dispose of
all or substantially all of their assets that
include the Enhanced Stoneville Assets
or the VipCot Assets, they shall require,
as a condition of the sale or other
disposition, that the purchaser(s) agree
to be bound by the provisions of this
Final Judgment. Defendants need not
obtain such an agreement from the
acquirers of the assets divested pursuant
to this Final Judgment.
IV. Divestiture of Enhanced Stoneville
Assets
A. Defendants are ordered and
directed, in accordance with the terms
of this Final Judgment, within ninety
(90) calendar days after the filing of the
Complaint in this matter, to divest the
Enhanced Stoneville Assets to an
acquirer acceptable to Plaintiff in
Plaintiff’s sole discretion. Defendants
shall use their best efforts to accomplish
the divestiture of the Enhanced
Stoneville Assets as expeditiously as
possible. Plaintiff, in its sole discretion,
may grant one or more extensions of this
time period, not to exceed sixty (60)
calendar days in total, and shall notify
the Court in each such circumstance.
B. Within two (2) business days
following execution of a definitive
agreement or agreements for the
divestiture of the Enhanced Stoneville
Assets, or the filing of this Final
Judgment, whichever is later,
Defendants shall notify Plaintiff in
writing of the proposed divestiture. The
notice shall set forth the details of the
proposed divestiture, including a list of
the name, address, and telephone
number of each person who offered, or
expressed an interest in or desire, to
acquire any ownership interest in the
Enhanced Stoneville Assets, together
with full details of the same. Defendants
need not include in this notice
information about any persons
previously identified in an affidavit
filed in compliance with this Final
Judgment as offering, or expressing an
interest in or desiring, to acquire any
ownership interest in the Enhanced
Stoneville Assets. Defendants shall
include with the notice a copy of the
PO 00000
Frm 00006
Fmt 4701
Sfmt 4703
divestiture agreement or agreements and
copies of any other agreements entered
into by either or both of the Defendants
and the proposed Acquirer of the
Enhanced Stoneville Assets since the
Complaint in this matter was filed, or
up to three (3) months before the filing
of the Complaint in this matter.
Defendants may incorporate by
reference in this notice any responsive
information or documents previously
provided to Plaintiff, provided that
Defendants identify with specificity
when the information or documents
were previously provided and, if the
information or documents were part of
a larger submission, where in the
submission the information or
documents may be located.
C. Within fifteen (15) calendar days of
receipt by Plaintiff of such notice,
Plaintiff may request from Defendants,
the proposed Acquirer of the Enhanced
Stoneville Assets, or any other third
party, additional information
concerning the proposed divestiture, the
proposed Acquirer of the Enhanced
Stoneville Assets, and any other
potential acquirer. Defendants shall
furnish any additional information
requested of Defendants within fifteen
(15) calendar days of the receipt of the
request, unless Defendants and Plaintiff
shall otherwise agree.
D. Within fifteen (15) calendar days
after receipt of the notice or within ten
(10) calendar days after Plaintiff has
been provided the additional
information requested from Defendants,
the proposed Acquirer of the Enhanced
Stoneville Assets, and any third party,
whichever is later, Plaintiff shall
provide written notice to Defendants
stating whether or not it objects to the
proposed divestiture. If Plaintiff
provides written notice that it does not
object, the divestiture may be
consummated. Absent written notice
that Plaintiff does not object to the
proposed Acquirer of the Enhanced
Stoneville Assets or upon objection by
Plaintiff, the divestiture of the Enhanced
Stoneville Assets to that proposed
Acquirer shall not be consummated.
E. The divestiture of the Enhanced
Stoneville Assets shall be accomplished
in such a way as to satisfy Plaintiff, in
its sole discretion, that the Enhanced
Stoneville Assets can and shall be used
by the Acquirer of the Enhanced
Stoneville Assets to operate a viable,
ongoing business engaged in the
development, production and sale of
traited cottonseed. The divestiture of the
Enhanced Stoneville Assets:
(1) Shall be made to an Acquirer of
the Enhanced Stoneville Assets that, in
Plaintiff’s sole judgment, has the intent
and capability (including the necessary
E:\FR\FM\15JNN2.SGM
15JNN2
rwilkins on PROD1PC63 with NOTICES2
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
managerial, operational, technical, and
financial capability and intellectual
property rights) of competing effectively
in the business of developing,
producing and selling traited cottonseed
in the United States, including a
credible commitment to the traited
cottonseed market;
(2) Shall be accomplished so as to
satisfy Plaintiff, in its sole discretion,
that the divestiture shall not result in
the substantial lessening of competition
for the development, production, and
sale of traited cottonseed in any
geographic area; and
(3) Shall be accomplished so as to
satisfy Plaintiff, in its sole discretion,
that none of the terms of any agreement
between an Acquirer of the Enhanced
Stoneville Assets and Defendants give
Defendants the ability unreasonably to
raise the Acquirer’s costs, to lower the
Acquirer’s efficiency, or otherwise to
interfere in the ability of the Acquirer to
compete effectively.
F. Defendants shall provide to the
Acquirer of the Enhanced Stoneville
Assets and Plaintiff information relating
to the personnel primarily involved in
the operation of Stoneville to enable the
Acquirer of the Enhanced Stoneville
Assets to make offers of employment.
Defendants shall not interfere with any
negotiations by the Acquirer of the
Enhanced Stoneville Assets to employ
any such personnel.
G. For a period of two (2) years from
the filing of the Complaint in this
matter, Defendants shall not solicit to
hire, or hire, any individual primarily
involved in the operation of Stoneville
on the date of the filing of the
Complaint in this matter who receives a
substantially equivalent offer of
employment from the Acquirer, unless
such individual is terminated or laid off
by the Acquirer, or the Acquirer agrees
that Defendants may solicit and employ
that individual.
H. Defendants shall not take any
action that shall impede in any way the
operation, use or divestiture of the
Enhanced Stoneville Assets.
I. Defendants shall warrant to the
Acquirer of the Enhanced Stoneville
Assets that there are no material defects
in the environmental, zoning or other
permits pertaining to the operation of
each asset that shall have a material
adverse effect on the operation of the
Enhanced Stoneville Assets, and that
following the sale of the Enhanced
Stoneville Assets, Defendants shall not
undertake, directly or indirectly, any
challenges to the environmental, zoning,
or other permits relating to the use or
operation of the Enhanced Stoneville
Assets based on actions or inactions that
existed prior to the date of divestiture.
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
V. Divestiture of VipCot Assets
A. Defendants are ordered and
directed, in accordance with the terms
of this Final Judgment, to offer Syngenta
the VipCot Assets listed in the attached
Schedule C within thirty (30) calendar
days of the filing of the Complaint in
this matter. The offer shall remain open
for at least six (6) months. Defendants
shall use their best efforts to accomplish
the divestiture of the VipCot Assets as
expeditiously as possible, but in any
event no later than ninety (90) calendar
days after the divestiture of the
Enhanced Stoneville Assets or thirty
(30) calendar days after Syngenta
accepts the offer, whichever is latest.
Plaintiff, in its sole discretion, may
extend the time period for Defendants to
divest the VipCot Assets to Syngenta by
granting one or more extensions, not to
exceed ninety (90) calendar days in
total, and shall notify the Court in each
such circumstance.
B. Prior to transmitting to Syngenta
the offer for the assets described in the
attached Schedule C, Defendants shall
provide Plaintiff with copies of the offer
for the approval of the Plaintiff in its
sole discretion. Along with the offer,
Defendants shall provide Plaintiff
copies of any other agreements not
previously provided to Plaintiff entered
into by either or both of the Defendants
and Syngenta since the Complaint in
this matter was filed, or up to three (3)
months before the filing of the
Complaint in this matter. Within five (5)
business days following receipt of the
offer, Plaintiff shall provide written
notice to Defendants stating whether the
offer must be amended to meet the
objectives of the divestiture of the
VipCot Assets. Absent written notice
that Plaintiff does not object to the offer,
the divestiture of the VipCot Assets to
Syngenta pursuant to the offer shall not
proceed. Upon objection by Plaintiff,
Defendants shall alter the terms of the
offer to satisfy Plaintiff in its sole
discretion.
C. Defendants shall permit Syngenta
to have reasonable access to personnel
and to any and all financial, operational,
or other documents and information
relating to the VipCot Assets
customarily provided as part of a due
diligence process.
D. Defendants shall not take any
action that shall harm the VipCot Assets
or impede in any way the divestiture of
the VipCot Assets.
VI. Changes in Third Party Licenses
A. Defendant Monsanto agrees to offer
to its licensees, within thirty (30)
calendar days of the date of the sale of
the Enhanced Stoneville Assets, to make
PO 00000
Frm 00007
Fmt 4701
Sfmt 4703
33341
the following changes to its third-party
cottonseed trait and Cotton States
licenses, subject to the approval of
Plaintiff in its sole discretion:
1. Current Cotton Insect Resistance
and Herbicide Tolerance Trait
Licensing—Agreements: Defendant
Monsanto shall modify its current
cottonseed trait licenses to provide the
licensees with the flexibility Defendant
DPL currently has to develop, market or
sell cottonseed containing nonMonsanto traits by removing any
provisions that require or incentivize
the licensee to develop, market or sell
cottonseed containing only traits from
Defendant Monsanto.
2. Cotton States Licenses: Defendant
Monsanto shall modify its Cotton—
States licenses to eliminate any
provision that allows Defendant
Monsanto to terminate the license if the
licensee sells cottonseed containing
non-Monsanto traits in brands not
licensed under the Cotton States license.
B. Prior to making the offers, and no
later than five (5) days after the date of
sale of the Enhanced Stoneville Assets,
Defendant Monsanto shall provide
Plaintiff with copies of the offers for the
approval of Plaintiff in its sole
discretion. Within five (5) days of
receipt of the offers to modify the
license agreements, Plaintiff shall
provide written notice to Defendant
Monsanto stating whether the offers
must be amended. Absent written notice
that Plaintiff does not object to the
offers, Defendant Monsanto may not
proceed with offering the modifications
to the licensees. Upon objection by
Plaintiff, Defendant Monsanto shall alter
the terms of the offers to satisfy Plaintiff
in its sole discretion. In the event any
of the licensees do not accept the offer
containing the modifications described
in Section VI.A. as approved by Plaintiff
in its sole discretion, Defendant
Monsanto shall act as though such
modification has been made and shall
not enforce any license provision that is
the subject of any such modification.
VII. Divestiture of Defendant DPL
A. If Defendants have not divested the
Enhanced Stoneville Assets by the end
of the time period permitted by this
Final Judgment, Defendants shall notify
Plaintiff of that fact in writing.
Defendant Monsanto shall then divest
DPL within sixty (60) days. If Defendant
Monsanto has not divested Defendant
DPL by the end of the sixty-day period,
Defendant Monsanto shall notify
Plaintiff of that fact in writing. Upon
application of Plaintiff, the Court shall
appoint a trustee selected by Plaintiff
and approved by the Court to effect the
divestiture of Defendant DPL.
E:\FR\FM\15JNN2.SGM
15JNN2
rwilkins on PROD1PC63 with NOTICES2
33342
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
B. Defendant Monsanto shall use its
best efforts to assist the trustee in
accomplishing the required divestiture
of Defendant DPL, including its best
efforts to effect all necessary regulatory
approvals. The trustee and any
consultants, accountants, attorneys, and
other persons retained by the trustee
shall have full and complete access to
the personnel, books, records, and assets
at the facilities to be divested, and
Defendant Monsanto shall develop
financial or other information relevant
to the assets to be divested customarily
provided in a due diligence process as
the trustee may reasonably request,
subject to reasonable protection for
confidential commercial information. In
addition, Defendant Monsanto shall:
(1) Permit prospective acquirers of
Defendant DPL who have been invited
to submit binding bids for Defendant
DPL to have reasonable access to
Defendant DPL’s personnel and to make
such inspection of Defendant DPL and
any and all financial, operational, or
other documents and other information
as may be relevant to the divestiture of
Defendant DPL, subject to reasonable
protection for confidential commercial
information;
(2) Provide the DPL Acquirer and
Plaintiff information relating to the
personnel of Defendant DPL to enable
the DPL Acquirer to make offers of
employment;
(3) Take no action to interfere with
any negotiations by the DPL Acquirer to
employ any Defendant DPL employee;
(4) Take no action to interfere with or
to impede the trustee’s accomplishment
of the divestiture of Defendant DPL;
(5) Warrant to the DPL Acquirer that
on the date of sale each asset shall be
in the same condition as when
Defendant Monsanto acquired
Defendant DPL, except for the
harvesting of cotton plants and selection
lines in the ordinary course of business,
and ordinary wear and tear of assets and
facilities;
(6) Warrant to the DPL Acquirer that
there are no material defects in the
environmental, zoning or other permits
pertaining to the operation of each asset
that have arisen since Defendant
Monsanto acquired Defendant DPL; and
(7) Shall not, following divestiture of
Defendant DPL, undertake, directly or
indirectly, any challenges to the
environmental, zoning, or other permits
relating to the operation of Defendant
DPL, or otherwise take any action that
shall impede in any way the permitting,
operation, or divestiture of Defendant
DPL.
C. Unless Plaintiff otherwise consents
in writing, the divestiture of Defendant
DPL pursuant to this Section of the
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
Final Judgment, whether accomplished
by Defendant Monsanto or a trustee,
shall include the entirety of Defendant
DPL, and shall be accomplished in such
a way as to satisfy Plaintiff, in its sole
discretion, that (a) Defendant DPL shall
remain no less viable than when
Defendant Monsanto acquired it, (b) the
divestiture of Defendant DPL shall
remedy the competitive harm alleged in
the Complaint, and (c) none of the terms
of any agreement between a DPL
Acquirer and Defendant Monsanto give
Defendant Monsanto the ability
unreasonably to raise that person’s
costs, to lower that person’s efficiency,
or otherwise to interfere in the ability of
that person to compete effectively.
D. The trustee shall have the power
and authority to accomplish the
divestiture of Defendant DPL at the
earliest possible time to an acquirer
acceptable to Plaintiff, in its sole
discretion, at such price and on such
terms as are then obtainable upon
reasonable effort by the trustee, and
shall have such other powers as the
Court deems appropriate. Subject to
Section VII.F of this Final Judgment, the
trustee shall have the power and
authority to hire at the cost and expense
of Defendant Monsanto any investment
bankers, attorneys, or other agents who
are reasonably necessary in the
judgment of the trustee to assist in the
divestiture of Defendant DPL and who
shall be solely accountable to the
trustee.
E. Defendant Monsanto shall not
object to a sale by the trustee on any
ground other than the trustee’s
malfeasance. Any such objections by
Defendant Monsanto must be conveyed
in writing to Plaintiff and the trustee
within ten (10) calendar days after the
trustee has provided the notice required
under this Section.
F. The trustee shall serve at the cost
and expense of Defendant Monsanto, on
such terms and conditions as Plaintiff
approves, and shall account for all
monies derived from the sale of the
assets sold by the trustee and all costs
and expenses so incurred. After
approval by the Court of the trustee’s
accounting, including fees for its
services and those of any professionals
and agents retained by the trustee, all
remaining money shall be paid to
Defendant Monsanto, and the trust shall
then be terminated. The compensation
of the trustee and of any professionals
and agents retained by the trustee shall
be reasonable in light of the value of
Defendant DPL and based on a fee
arrangement providing the trustee with
an incentive based on the price and
terms of the divestiture of Defendant
DPL and the speed with which it is
PO 00000
Frm 00008
Fmt 4701
Sfmt 4703
accomplished, but timeliness is
paramount.
G. After its appointment, the trustee
shall file monthly reports with Plaintiff,
Defendant Monsanto, and the Court
setting forth the trustee’s efforts to
accomplish the divestiture of Defendant
DPL, provided however, that to the
extent such reports contain information
that the trustee deems confidential, such
reports shall not be filed in the public
docket of the Court and Defendant
Monsanto’s copy of the report shall have
such confidential information redacted.
Such reports shall include the name,
address, and telephone number of each
person who, during the preceding
month, made an offer to acquire,
expressed an interest in acquiring,
entered into negotiations to acquire, or
was contacted or made an inquiry about
acquiring, any interest in Defendant
DPL, and shall describe in detail each
contact with any such person during
that period. The trustee shall maintain
full records of all efforts made to divest
Defendant DPL.
H. If the trustee has not accomplished
such divestiture of Defendant DPL
within ninety (90) calendar days after its
appointment, the trustee shall file
promptly with the Court a report setting
forth (1) The trustee’s efforts to
accomplish the required divestiture of
Defendant DPL; (2) the reasons, in the
trustee’s judgment, why the required
divestiture of Defendant DPL has not
been accomplished; and (3) the trustee’s
recommendations. To the extent such
report contains information that the
trustee deems confidential, such report
shall not be filed in the public docket
of the Court. The trustee shall at the
same time furnish such report to
Plaintiff. Plaintiff shall have the right to
make additional recommendations
consistent with the purpose of the trust.
The Court shall enter thereafter such
orders as it shall deem appropriate to
carry out the purpose of this Final
Judgment which may, if necessary,
include extending this Final Judgment
and the term of the trustee’s
appointment by a period requested by
Plaintiff.
I. The trustee shall notify Plaintiff and
Defendant Monsanto within two (2)
business days following execution of a
definitive agreement for the sale of
Defendant DPL. The notice shall set
forth the details of the proposed
divestiture of Defendant DPL and list
the name, address, and telephone
number of each person not previously
identified who offered or expressed an
interest in or desire to acquire any
ownership interest in Defendant DPL,
together with full details of the same.
E:\FR\FM\15JNN2.SGM
15JNN2
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
J. Within fifteen (15) calendar days of
receipt by Plaintiff of such notice,
Plaintiff may request from Defendants,
the proposed DPL Acquirer, any other
third party, or the trustee, additional
information concerning the proposed
divestiture of Defendant DPL, the
proposed DPL Acquirer, and any other
potential acquirer. Defendants and the
trustee shall furnish any additional
information requested within fifteen
(15) calendar days of the receipt of the
request, unless the Defendants and
Plaintiff shall otherwise agree.
K. Within thirty (30) calendar days
after receipt of the notice or within
twenty (20) calendar days after Plaintiff
has been provided the additional
information requested from Defendant
Monsanto, the proposed DPL Acquirer,
any third party, and the trustee,
whichever is later, Plaintiff shall
provide written notice to Defendant
Monsanto and the trustee stating
whether or not it objects to the proposed
divestiture of Defendant DPL. If Plaintiff
provides written notice that it does not
object, the sale of Defendant DPL may
be consummated, subject only to
Defendant Monsanto’s limited right to
object to the sale under Section VII.E of
this Final Judgment. Absent written
notice that Plaintiff does not object to
the proposed DPL Acquirer or upon
objection by Plaintiff, the sale of
Defendant DPL shall not be
consummated. Upon objection by
Defendant Monsanto under Section
VII.E, a sale of Defendant DPL proposed
under this Section shall not be
consummated unless approved by the
Court.
VIII. Financing
Defendants shall not finance all or
any part of any purchase made pursuant
to Section IV or Section VII of this Final
Judgment.
rwilkins on PROD1PC63 with NOTICES2
IX. Hold Separate
Until the divestitures required by this
Final Judgment have been
accomplished, Defendants shall take all
steps necessary to comply with the Hold
Separate and Preservation of Assets
Stipulation and Order entered by this
Court. Defendants shall take no action
that would jeopardize the divestitures
ordered by this Court.
X. Affidavits
A. Within ten (10) calendar days of
the filing of the Complaint in this
matter, and every thirty (30) calendar
days thereafter until the divestitures
have been completed under Sections IV
and V, Defendants shall deliver to
Plaintiff an affidavit as to the fact and
manner of its compliance with Sections
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
IV, V, and VI of this Final Judgment.
Each such affidavit shall include the
name, address, and telephone number of
each person who, during the preceding
thirty days, made an offer to acquire,
expressed an interest in acquiring,
entered into negotiations to acquire, or
was contacted or made an inquiry about
acquiring, any interest in the Enhanced
Stoneville Assets, and shall describe in
detail each contact with any such
person during that period, including a
summary of all conversations (1)
Between Defendants and any Acquirer
of the Enhanced Stoneville Assets, and
(2) between Defendants and Syngenta
with respect to the VipCot Assets.
Defendants may incorporate by
reference in any such affidavit any
responsive information or documents
previously provided to Plaintiff,
provided however, that Defendants
identify with specificity when the
information or documents were
previously provided and, if the
information or documents were part of
a larger submission, where in the
submission the information or
documents may be located. Assuming
the information set forth in the affidavit
is true and complete, any objection by
Plaintiff to information provided by
Defendants, including any limitation on
information, shall be made within
fourteen (14) days of receipt of such
affidavit.
B. Defendants shall keep all records of
all efforts made to preserve and divest
the Enhanced Stoneville Assets and
VipCot Assets until one year after each
such divestiture has been completed.
XI. Compliance Inspection
A. For the purposes of determining or
securing compliance with this Final
Judgment, or of determining whether
the Final Judgment should be modified
or vacated, and subject to any legally
recognized privilege, from time to time
duly authorized representatives of the
United States Department of Justice,
including consultants and other persons
retained by the United States, shall,
upon written request of a duly
authorized representative of the
Assistant Attorney General in charge of
the Antitrust Division, and on
reasonable notice to Defendants, be
permitted:
(1) Access during Defendants’ office
hours to inspect and copy, or at
Plaintiffs option, to require Defendants
to provide copies of all books, ledgers,
accounts, records and documents in the
possession, custody, or control of
Defendants, relating to any matters
contained in this Final Judgment; and
(2) To interview, either informally or
on the record, Defendants’ officers,
PO 00000
Frm 00009
Fmt 4701
Sfmt 4703
33343
employees, or agents, who may have
their individual counsel present,
regarding such matters. The interviews
shall be subject to the reasonable
convenience of the interviewee and
without restraint or interference by
Defendants.
B. Upon the written request of a duly
authorized representative of the
Assistant Attorney General in charge of
the Antitrust Division, Defendants shall
submit written reports or responses to
written interrogatories, under oath if
requested, relating to any of the matters
contained in this Final Judgment as may
be requested.
C. No information or documents
obtained by the means provided in this
Section shall be divulged by Plaintiff to
any person other than an authorized
representative of the executive branch of
the United States, except in the course
of legal proceedings to which the United
States is a party (including grand jury
proceedings), or for the purpose of
securing compliance with this Final
Judgment, or as otherwise required by
law.
D. If, at the time information or
documents are furnished by Defendants
to Plaintiff, Defendants represent and
identify in writing the material in any
such information or documents to
which a claim of protection may be
asserted under Rule 26(c)(7) of the
Federal Rules of Civil Procedure, and
Defendants mark each pertinent page of
such material, ‘‘Subject to claim of
protection under Rule 26( c)(7) of the
Federal Rules of Civil Procedure,’’ then
Plaintiff shall give Defendants ten (10)
calendar days’ notice prior to divulging
such material in any legal proceeding
(other than a grand jury proceeding).
XII. Notification
A. Unless such transaction is
otherwise subject to the reporting and
waiting period requirements of the HartScott-Rodino Antitrust Improvements
Act of 1976, as amended, 15 U.S.C. 18a
(the ‘‘HSR Act’’), Defendant Monsanto,
without providing advance notification
to Plaintiff, shall not directly or
indirectly acquire (1) Voting securities,
(2) all or substantially all of the cotton
germplasm, or (3) substantially all of the
assets relating to cottonseeds or
cottonseed traits, of any company that
develops and sells cottonseed in the
United States, or any company that has
developed, or has under development
traits for commercialization in
cottonseed in the United States, where
such acquisition would be reportable
under the HSR Act but for a failure to
satisfy the thresholds of 15 U.S.C.
l8a(a)(2).
E:\FR\FM\15JNN2.SGM
15JNN2
33344
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
B. Such notification shall be provided
to Plaintiff in the same format as, and
per the instructions relating to the
Notification and Report Form set forth
in the Appendix to Part 803 of Title 16
of the Code of Federal Regulations as
amended, except that the information
requested in Items 5 through 9 of the
instructions must be provided only
about cottonseeds or transgenic traits
that shall be or could be used in
cottonseeds. Notification shall be
provided at least thirty (30) days prior
to acquiring any such interest, and shall
include, beyond what may be required
by the applicable instructions, the
names of the principal representatives
of the parties to the agreement who
negotiated the agreement, and any
management or strategic plans
discussing the proposed transaction. If
within the thirty (30) day period after
notification, representatives of Plaintiff
make a written request for additional
information, Defendant Monsanto shall
not consummate the proposed
transaction or agreement until twenty
(20) days after submitting all such
additional information. Early
termination of the waiting periods in
this paragraph may be requested and,
where appropriate, granted in the same
manner as is applicable under the
requirements and provisions of the HSR
Act and rules promulgated thereunder.
This Section shall be broadly construed
and any ambiguity or uncertainty
regarding the filing of notice under this
Section shall be resolved in favor of
filing notice.
XIII. No Reacquisition
If Defendant Monsanto divests the
Enhanced Stoneville Assets and the
VipCot Assets, Defendant Monsanto
may not reacquire any part of the
Enhanced Stoneville Assets or the
VipCot Assets during the term of this
Final Judgment. If Defendant Monsanto
divests Defendant DPL, it may not
reacquire any part of Defendant DPL
during the term of this Final Judgment.
rwilkins on PROD1PC63 with NOTICES2
XIV. Retention of Jurisdiction
This Court retains jurisdiction to
enable any party to this Final Judgment
to apply to this Court at any time for
further orders and directions as may be
necessary or appropriate to carry out or
construe this Final Judgment, to modify
any of its provisions, to enforce
compliance, and to punish violations of
its provisions.
XV. Expiration of Final Judgment
Unless this Court grants an extension,
this Final Judgment shall expire ten (10)
years from the date of its entry.
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
XVI. Public Interest Determination
Entry of this Final Judgment is in the
public interest. The parties have
complied with the requirements of the
Antitrust Procedures and Penalties Act,
15 U.S.C. 16, including making copies
available to the public of this Final
Judgment, the Competitive Impact
Statement, and any comments thereon
and Plaintiff’s responses to comments.
Based upon the record before the Court,
which includes the Competitive Impact
Statement and any comments and
response to comments filed with the
Court, entry of this Final Judgment is in
the public interest.
Date: llllllllllllllll
Court approval subject to procedures of
Antitrust Procedures and Penalties Act,
15 U.S.C. 16.
llllllllllllllllll
l
United States District Judge
Definitions for Schedules
1. ‘‘Advanced Exotic Yield Lines’’
means the Breeding populations and
proprietary Lines created by Defendant
Monsanto from a cross between
Gossypium hirsutum and Gossypium
barbadense that are identified in
Schedule D.
2. ‘‘Backcross’’ means to cross a
hybrid with one of its parents and then
to cross the resulting progeny with the
same parent Line (perhaps multiple
times) in order to develop progeny with
a genetic makeup that approximates the
genetic make up of that parent while
retaining certain desirable
characteristics of the genetic makeup of
the other parent of the hybrid.
3. ‘‘Breed’’ means to purposefully
modify the Germplasm of a plant so as
to alter its genetic make up, and to
develop the progeny from the altered
Germplasm.
4. ‘‘DPL Marker Data’’ means
Fingerprints that Defendant Monsanto
shall create for the DPL Germplasm
being divested pursuant to Schedule
B.2.
5. ‘‘Donor Lines’’ means the cotton
Lines used by Defendant Monsanto to
create or transmit novel cotton traits or
events, and identified in Schedule F.
6. ‘‘Fingerprint’’ means a record of the
presence or absence of genetic markers
for which a Line has been tested.
7. ‘‘Germplasm’’ means a collection of
heterozygous and homozygous cotton
plants or parts thereof. For purposes of
Schedules B and C of this Final
Judgment, when the Defendants are
required to convey Germplasm to a
party, the Defendant may satisfy that
obligation by conveying that Germplasm
in seed form, or if necessary, in potted
plant form.
PO 00000
Frm 00010
Fmt 4701
Sfmt 4703
8. ‘‘Introgress’’ means to move a gene
from one cotton plant into another.
9. ‘‘Line’’ means a set of cottonseed or
plants that share a common reasonably
homogenous genotype that originate
from a cross between two cotton plants.
10. ‘‘MAB Populations’’ means the
Germplasm populations for which
Defendant Monsanto has conducted
significant marker analyses that are
identified in Schedule E.
11. ‘‘Monsanto B.t. Gene’’ means a
DNA molecule, or a replicate thereof,
developed and out-licensed by
Defendant Monsanto for use in
commercial cottonseed in the United
States, and which encodes a B.t. toxin
that when present in cotton plants
results in those plants being toxic to
lepidopteran insects.
12. ‘‘Monsanto Cotton Traits’’ means:
(1) The transgenic event denominated
‘‘Event 531’’ currently sold under the
‘‘Bollgard’’ brand; (2) the transgenic
event denominated ‘‘Event 15985’’
currently sold under the ‘‘Bollgard II’’
brand; (3) the transgenic event
denominated ‘‘Event 1445’’ currently
sold under the ‘‘Roundup Ready’’ brand;
and (4) the transgenic event
denominated ‘‘Event 88913’’ currently
sold under the ‘‘Roundup Ready Flex’’
brand, or any combination thereof.
13. ‘‘Monsanto Marker Library’’
means (1) Two collections of genetic
information concerning variations in the
genetic makeup of Gossypium,
specifically a set of SSRs and a set of
SNPs, and (2) cotton mapping data
owned by Defendant Monsanto prior to
its acquisition of Defendant DPL
pursuant to the Merger Agreement.
14. ‘‘Monsanto Roundup Ready Gene’’
means a DNA molecule, or a replicate
thereof, developed and out-licensed by
Defendant Monsanto for use in
commercial cottonseed in the United
States, and which when present in
cotton plants results in those plants
exhibiting commercial tolerance to
glyphosate herbicides.
15. ‘‘Null Line’’ shall mean a
reasonably genetically homogenous Line
of cotton that is selected from a cross in
which one of the parents was from the
Advanced Exotic Yield Lines or MAB
populations and that does not contain
one or more of the Monsanto Cotton
Traits that was contained in the parental
Advanced Exotic Yield Line or MAB
population. A grant of a right to create
a Null Line to the Acquirer of the
Enhanced Stoneville Assets includes an
obligation by Defendant Monsanto to
provide the Acquirer of the Enhanced
Stoneville Assets with assays, materials,
and information regarding the Monsanto
Cotton Trait(s) formerly in the Null Line
necessary to obtain requisite regulatory
E:\FR\FM\15JNN2.SGM
15JNN2
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
rwilkins on PROD1PC63 with NOTICES2
approvals, provided the Acquirer of the
Enhanced Stoneville Assets reimburses
Defendant Monsanto its reasonable
expenses in providing such assistance.
16. ‘‘Publicly Available Cotton
Germplasm’’ means any non-Monsanto
proprietary cotton Germplasm that has
not been exclusively in-licensed by
Defendant Monsanto.
17. ‘‘Recurrent Parent’’ means the
parent to which successive Backcrosses
are made in Backcross Breeding.
18. ‘‘Roundup Ready Flex’’ means the
Monsanto Roundup Ready Gene
denominated ‘‘Event 88913.’’
19. ‘‘SNP’’ (or Single Nucleotide
Polymorphisms) means variations at a
single position in a given DNA
sequence, which occur within a
population of cotton plants.
20. ‘‘SSR’’ (or Simple Sequence
Repeat) means variations in the number
of repetitions of a DNA sequence.
21. ‘‘Transform’’ means to alter the
genetic makeup of a cotton plant variety
through means other than Breeding, for
example, by the introduction of foreign
genetic material.
Schedule A—Stoneville
1. Cotton Germplasm: All U.S.
Stoneville cotton Germplasm, including,
for each variety, Line and population to
be divested: all patents, patent
applications and Plant Variety
Protection Act certificates applied for or
granted with respect to that Germplasm
(and excluding any patents or patent
applications on Monsanto cotton traits);
and copies of all performance and other
test results, phenotypic data, product
descriptions, research data and any
Fingerprint information.
2. Physical Assets:
a. Defendant Monsanto’s interest in
the real property at the following sites
or locations:
(1) The manufacturing, storage and
delinting facility at Stoneville,
Mississippi;
(2) The research & development
facility at Arcola, Mississippi;
(3) The research & development
facility, including greenhouse and labs,
at Memphis, Tennessee; and
(4) The manufacturing, storage and
delinting and the Breeding and testing
facilities at N. Powerline Road,
Maricopa, Arizona.
b. Defendant Monsanto’s interest in
the leased real property at the following
sites or locations:
(1) The land at Maricopa, Arizona;
(2) The AgriCenter international
research facility at Memphis, Tennessee;
(3) The Memphis Redbirds Suite;
(4) The Columbus & Greenville
Railway Lease;
(5) The delinting plant at Marble Hall,
South Africa;
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
(6) The property described in the W.B.
Sutton Farms Partnership Lease;
(7) The storage facility described in
the Farmers Feed Storage Agreement;
(8) The storage facility described in
the David Storage Company Industrial
Space Lease; and
(9) The storage facility described in
the Cascio Refrigerated Warehouse
Agreement.
c. At the option of the Acquirer of the
Enhanced Stoneville Assets, Defendant
Monsanto’s interest in the real property
at the following sites or locations:
(1) The farm at Lubbock, Texas;
(2) The manufacturing, storage, and
delinting facility at Big Spring, Texas;
(3) The research and development
facility at Idalou, Texas;
(4) 7.2 acres in Idalou, Texas (leased);
and
(5) 80 acres in Idalou, Texas (leased).
d. All tangible assets other than
Germplasm located at each of the
locations identified in a. and b. above
that are exclusively or primarily used in
connection with the Stoneville U.S.
branded business, including:
(1) All manufacturing and agricultural
equipment, tooling and fixed assets;
personal property; materials; supplies;
and other tangible property.
(2) All existing drawings; blueprints;
designs; plans for improvements or
expansion; design protocols;
specifications for materials; and
specifications for parts and devices.
(3) All safety procedures for the
handling of materials and substances;
and quality assurance and control
procedures relating to the locations
listed in a. and b. above or the tangible
assets listed in this paragraph d.
(4) Business records relating to the
Stoneville U.S. branded cottonseed
business, including stock record books,
minute books, direct customer or direct
distributor lists; a list of names and
addresses of U.S. cotton growers with
Monsanto trait licenses; and other
information to the extent related to the
operation of the business during the
past three years which is in the
possession of or available to the
Defendants.
e. At the option of the Acquirer of the
Enhanced Stoneville Assets, all tangible
assets other than Germplasm located at
each of the locations identified in c.
above that are exclusively or primarily
used in connection with the Stoneville
U.S. branded business, including:
(1) All manufacturing and agricultural
equipment, tooling and fixed assets;
personal property; materials; supplies;
and other tangible property.
(2) All existing drawings; blueprints;
designs; plans for improvements or
expansion; design protocols;
PO 00000
Frm 00011
Fmt 4701
Sfmt 4703
33345
specifications for materials; and
specifications for parts and devices.
(3) All safety procedures for the
handling of materials and substances;
and quality assurance and control
procedures relating to the locations
listed in c. above or the tangible assets
listed in this paragraph e.
(4) Business records relating to the
Stoneville U.S. branded cottonseed
business, including stock record books,
minute books, direct customer or direct
distributor lists; a list of names and
addresses of U.S. cotton growers with
Monsanto trait licenses; and other
information to the extent related to the
operation of the business during the
past three years which is in the
possession of or available to the
Defendants.
f. At the option of the Acquirer of the
Enhanced Stoneville Assets, all
equipment used exclusively or
primarily in connection with the
Stoneville branded cottonseed business
stored at Monsanto sites at Leesburg,
Georgia, Mt. Olive, North Carolina and
Leland, Mississippi.
3. Intangible Assets:
a. Brand Names, Goodwill and Trade
Secrets—The Stoneville brand names,
goodwill, and trade secrets relating to
Stoneville’s U.S. branded cottonseed
business. Defendant Monsanto may
retain exclusive rights to the Stoneville
brand in connection with the sale of
Germplasm in Spain, Greece, and
Turkey, such rights expire on a countryby-country basis with the term of the
relevant current distributor agreements
in Spain and Greece, and one (1) year
from the date of divestiture of the
Enhanced Stoneville Assets in Turkey,
provided that in all cases the relevant
distributors shall be allowed to sell any
inventory of goods already packaged in
containers bearing the Stoneville
trademarks as of the relevant
termination date.
b. Intangible and Contractual Rights:
(1) Exclusive rights to (a) Breeder
records and/or notebooks, including
pedigrees, relating to Stoneville U.S.
cotton Germplasm, identities of nonpublic lines of Stoneville U.S. cotton
Germplasm in breeding and trial results,
including yield results (subject to the
redaction of any data that may be
included in such records relating to the
identity of any non-public lines other
than Stoneville U.S. cotton Germplasm),
(b) existing fingerprints for Stoneville
U.S. cotton Germplasm, and (c) quality
control data relating to Stoneville U.S.
cotton Germplasm (subject to Defendant
Monsanto’s right to keep under the
control of its Law Department (i) one
copy of such quality control data and
(ii) access to the identities of any
E:\FR\FM\15JNN2.SGM
15JNN2
33346
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
rwilkins on PROD1PC63 with NOTICES2
Stoneville U.S. cotton Germplasm
present in trial results that also include
results relating to non-public lines of
Germplasm other than Stoneville U.S.
cotton Germplasm; Monsanto’s Law
Department may not disclose this
information to any other component of
Monsanto).
(2) Non-exclusive rights to, and the
tangible embodiments of, (i) Nonproprietary procedures, methods,
techniques, know-how, specifications,
processes, analyses, and protocols used
in Stoneville’s U.S. branded cottonseed
business (such as Monsanto’s
procedures for the inspection, sampling
and delivery of cottonseed at production
facilities, procedures for analyzing job
safety and complying with
environmental regulations, and
specifications for production-related
data entry), and (ii) Monsanto’s low acid
delinting process.
(3) All assignable licenses, permits,
and authorizations issued by any
governmental organization relating to
the Stoneville U.S. branded cottonseed
business.
(4) All contracts to which Stoneville
Pedigreed Seed Company is a party,
including supply and distribution
agreements.
(5) All other intangible and
contractual rights used exclusively or
primarily in Stoneville’s U.S. branded
cottonseed business not otherwise
specifically addressed in b.(1 )–(4).
4. Exclusions:
Excluded from the assets to be
divested that are listed in this Schedule
A are: (1) Real property not specifically
identified in Schedule A.2., and (2)
software owned by or licensed to
Defendant Monsanto (except that
Stoneville will receive a non-exclusive
license to TaqPro), and hardware used
exclusively to access such software.
Schedule B—Enhanced Stoneville
Assets
1. Stoneville: As defined in the Final
Judgment.
2. DPL Germplasm: Defendants shall
divest all interests in the DPL varieties
listed in Table B, including, for each
variety, any Plant Variety Protection Act
certificates applied for or granted,
patents applied for or granted, copies of
all performance and other test results,
phenotypic data, product descriptions,
research data and DPL Marker Data.
a. With respect to this DPL
Germplasm, Defendant Monsanto may:
(1) Continue to sell during 2007 any
existing inventories of these DPL
varieties that Defendant DPL currently
offers for sale in the United States;
(2) Take back an exclusive license to
commercialize varieties that (i) Contain
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
only traits out-licensed by Defendant
Monsanto, and (ii) are essentially
derived from these DPL varieties, or are
essentially derived from a cross between
any of these DPL varieties, which
license may require the Acquirer of the
Enhanced Stoneville Assets to seek U.S.
patents for the DPL varieties listed in
Table B, and may provide for
enforcement of Monsanto’s exclusive
rights with respect to these varieties;
(3) Retain exclusive rights (i) To
continue to sell these DPL varieties in
countries outside the United States in
which Defendant DPL currently offers
the varieties for sale, but such rights
shall terminate with respect to a
particular country and variety if
Defendant Monsanto discontinues sales
of that variety in that country, and (ii)
to sell 05X460, 05Y063, and 05Z629
outside of the United States;
(4) Retain sufficient quantities of
cottonseed to enable it to continue its
current sales of seed relating to sales
made pursuant to subparagraph 3 above
(provided that any such retention by
Defendant Monsanto shall only be
permitted to the extent it does not
adversely affect the Acquirer of the
Enhanced Stoneville Assets);
(5) Retain sufficient quantities of
cottonseed for Breeding purposes
(provided that any such retention by
Defendant Monsanto shall only be
permitted to the extent it does not
adversely affect the Acquirer of the
Enhanced Stoneville Assets), and take
back a non-exclusive license to use
these DPL varieties in its Breeding
program;
(6) Take back a license that grants
Defendant Monsanto only those rights
necessary to accomplish the divestiture
of the VipCot Assets described in
Schedule C; and
(7) Require the Acquirer of the
Enhanced Stoneville Assets to agree that
for seven (7) years after the divestiture
of the Enhanced Stoneville Assets it
shall not commercialize a variety that is
essentially derived from one of the DPL
varieties listed in Table B, if that variety
contains a Monsanto glyphosate
tolerance trait, a Monsanto insect
resistance trait, and any non-glyphosate
herbicide tolerance trait commercialized
in cottonseed in the United States as of
the date of the filing of this Final
Judgment.
b. Defendants’ divestiture of the DPL
varieties 00W12, 02T15, 02Z55, 03Y047,
03Y056, 03Y062, 04T048, 04W019,
04Y341, 05X460, 05Y063, 05Z629,
25105N, and DP491 to the Acquirer of
the Enhanced Stoneville Assets is
subject to the license to Syngenta
described in Schedule C.2.
PO 00000
Frm 00012
Fmt 4701
Sfmt 4703
3. Syngenta Germplasm: Defendants
shall divest all interests in the
conventional Germplasm originating
from the United States cotton Breeding
program purchased by Defendant DPL
from Syngenta pursuant to an agreement
dated May 15, 2006, along with any
conventional progeny of that material.
4. Advanced Exotic Yield Lines:
Defendants shall divest exclusive rights
to commercialize, and non-exclusive
rights to Breed with, the Advanced
Exotic Yield Lines set forth in Schedule
D, including the right, subject to
reasonable indemnification
requirements, to create Null Lines (other
than a Null Line that contains only one
of the B.t. Genes of Bollgard II). In
connection with this divestiture:
a. Defendants shall divest copies of all
performance and other test results,
phenotypic data, product descriptions,
research data and Fingerprint
information for those populations and
Lines, excluding data regarding the
presence or function of any genetic
material from Gossypium barbadense
present in the Lines.
b. Defendants may not assert against
the Acquirer of the Enhanced Stoneville
Assets any rights Defendants may have
or acquire with respect to (1) The
Germplasm used in the Advanced
Exotic Yield Lines, and (2) any nontransgenic yield trait contained in those
Lines.
c. Defendants may retain research
quantities of the Advanced Exotic Yield
Lines to enable them to continue their
trait development research (provided
that any such retention by Defendant
Monsanto shall only be permitted to the
extent it does not adversely affect the
Acquirer of the Enhanced Stoneville
Assets); and
d. Defendants may (1) Prohibit the
Acquirer of the Enhanced Stoneville
Assets from conveying Lines from the
Advanced Exotic Yield Lines or their
progeny to third parties, other than for
contract production work or for
distribution to growers as commercial
seed, and (2) require the Acquirer of the
Enhanced Stoneville Assets to seek U.S.
patents and enforce Breeding and resale
restrictions on any varieties that are
commercialized from the Advanced
Exotic Yield Lines. Defendants shall
lose the ability to require these terms
(4.d.1 & 2) if Defendants have not
licensed to a third party a nontransgenic cotton yield trait contained
in one or more of the Advanced Exotic
Yield Lines within five (5) years of the
date of this Final Judgment.
5. MAB Populations: Defendants shall
divest the MAB Populations set forth in
Schedule E, including copies of all
performance and other test results,
E:\FR\FM\15JNN2.SGM
15JNN2
rwilkins on PROD1PC63 with NOTICES2
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
phenotypic data, product descriptions,
research data and Fingerprint
information, and the right, subject to
reasonable indemnification
requirements, to create Null Lines (other
than a Null Line that contains only one
of the B.t. genes of Bollgard II).
6. Cotton States Germplasm:
Defendant Monsanto shall grant the
Acquirer of the Enhanced Stoneville
Assets a non-exclusive, royalty-free
license to sell under the Stoneville and
NexGen brand names and Breed with
the four (4) Cotton States varieties
currently being sold by Stoneville.
Defendant Monsanto shall relinquish
evaluation rights to the Acquirer of the
Enhanced Stoneville Assets for material
comprised of Germplasm from preexisting Breeding crosses between
Cotton States’ in-licensed Lines and any
Lines being transferred exclusively to
Stoneville pursuant to this Final
Judgment.
a. In connection with its divestiture of
this Cotton States Germplasm,
Defendant Monsanto may retain
exclusive rights to Germplasm already
in-licensed to or commercialized
through Cotton States at the date of this
Final Judgment, or Germplasm from preexisting Breeding crosses between two
Cotton States’ in-licensed Lines or
between one of those Lines and a public
variety, except that Defendant Monsanto
may only retain non-exclusive rights to
the Stoneville variety designated
STX0502 which has been
commercialized solely through Cotton
States. Defendant Monsanto may only
commercialize the Stoneville variety
designated STX0502 to licensees other
than Defendant DPL.
7. Other Monsanto Germplasm:
Defendants shall divest all cotton
Germplasm in the United States held by
Defendant Monsanto prior to its
acquisition of Defendant DPL and not
otherwise addressed in Schedules A and
B, subject to the following exceptions:
a. Any Publicly Available Cotton
Germplasm, provided that if the
Acquirer of the Enhanced Stoneville
Assets does not otherwise possess the
Germplasm and cannot otherwise
reasonably obtain it, Defendant
Monsanto must, if the Acquirer of the
Enhanced Stoneville Assets requests,
provide the Acquirer of the Enhanced
Stoneville Assets with sufficient
quantities for use in a Breeding
program;
b. Exclusive rights to (1) The Donor
Lines for Defendant Monsanto’s
commercialized transgenic traits, (2)
Germplasm Transformed or Introgressed
with cotton transgenic traits other than
Monsanto’s Cotton Traits, (3) any
Germplasm containing experimental
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
transgenic events, and (4) Germplasm
used in Monsanto’s non-transgenic trait
research and development program,
with the exception of the Advanced
Exotic Yield Lines, as addressed above;
and
c. Rights to any third party
Germplasm held in connection with the
provision of trait Introgression services
to third parties.
8. Monsanto Marker Library:
Defendants shall provide access to the
information in, and a non-exclusive,
royalty-free license to use, Monsanto’s
Marker Library.
9. Licenses: Defendants shall grant
licenses to the Acquirer of the Enhanced
Stoneville Assets to develop, produce,
have produced, and sell under the
Stoneville and NexGen brands
cottonseed containing Monsanto’s
Cotton Traits for use in the United
States. Such licenses shall be based on
commercially reasonable terms, and in
particular shall provide that the
licensee:
a. Shall be entitled to a proportion of
the net license revenue for those traits
at least as great as the net license
revenue Defendant DPL is entitled to
under its current licenses for those
traits;
b. May, subject to reasonable
regulatory and stewardship conditions,
Breed into and sell cottonseed
containing Monsanto Cotton Traits, nonMonsanto genes not naturally occurring
in cotton;
c. Shall have an option to license
future Monsanto B.t. Genes on the same
terms as those used in the current DPL
licenses. Defendants may terminate this
option at such time as the Acquirer of
the Enhanced Stoneville Assets’ total
annual sales of cottonseed containing a
non-Monsanto B.t. Gene being marketed
by the Acquirer of the Enhanced
Stoneville Assets as conferring
lepidopteran resistance under the
Stoneville and NexGen brands, exceed
60% of the Acquirer of the Enhanced
Stoneville Assets’ annual sales of
cottonseed that is marketed as
lepidopteran resistant under the
Stoneville and NexGen brands; and
d. Shall have an option to license
future Monsanto Roundup Ready Genes
on the same terms as those used in the
current DPL licenses. Defendants may
terminate this option at such time as the
Acquirer of the Enhanced Stoneville
Assets’ total annual sales of cottonseed
containing a non-Monsanto glyphosate
tolerance gene being marketed by the
Acquirer of the Enhanced Stoneville
Assets as conferring glyphosate
tolerance under the Stoneville and
NexGen brands, exceed 60% of the
Acquirer of the Enhanced Stoneville
PO 00000
Frm 00013
Fmt 4701
Sfmt 4703
33347
Assets’ annual sales of cottonseed that
is marketed as glyphosate tolerant under
the Stoneville and NexGen brands.
Defendants need not grant an option to
any non-glyphosate herbicide tolerance
trait stacked with any such glyphosate
tolerance gene.
TABLE B.—DPL GERMPLASM
00W12 (DP393):
02T15
02Z55
03Y047
03Y056
03Y062
04T048
04W019
04Y341
05X460
05Y063
05Z629
Delta Pearl
DP 5690
DP 491
DP2156
DP565
DP5305
DP5415
AZ2099
Schedule C—The VipCot Assets
1. All DPL Germplasm identified in
Table C containing only a Syngenta
trait; and, provided that Syngenta has
obtained a license (identified in Section
C.4. below) to the Roundup Ready Flex
trait, all DPL Germplasm Lines
identified in Table C containing a
Syngenta trait and the Roundup Ready
Flex trait. The Germplasm Lines
identified in Table C shall be conveyed
along with:
a. Exclusive rights to commercialize
varieties developed from the traited DPL
Germplasm Lines identified in Table C,
provided that any varieties
commercialized from this Germplasm
include, in addition to any other traits,
the Cry67B event, Cry69D event,
Cry02A event, or the Cot102 event;
b. Exclusive rights to Breed with the
traited DPL Germplasm Lines identified
in Table C, provided that any varieties
commercialized from such Breeding
include, in addition to any other traits,
either the Cry67B event, Cry69D event,
Cry02A event, or the Cot102 event;
c. Reports that provide all
performance and other test results,
phenotypic data, product descriptions,
purity information, breeding histories,
pedigrees and statuses for the
Germplasm that is conveyed;
d. At Syngenta’s request, Fingerprint
information regarding the Recurrent
Parents of each of the DPL Germplasm
Lines listed in Table C sufficient to
allow Syngenta to reasonably perform
Backcrossing with this Germplasm
E:\FR\FM\15JNN2.SGM
15JNN2
33348
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
rwilkins on PROD1PC63 with NOTICES2
(subject to reasonable compensation
from Syngenta for such services), if
Syngenta does not possess, cannot
reasonably develop itself or contract for,
the capability to develop this
Fingerprint information; and
e. An exclusive license to
commercialize varieties that contain the
Cry67B event, Cry69D event, Cry02A
event, or Cot102 event that are
essentially derived from the Recurrent
Parent Lines identified in Table C that
are not otherwise being divested
pursuant to Schedule B, which license
shall require Monsanto to seek U.S.
patents for those Recurrent Parent Lines
and provide for enforcement of
Syngenta’s exclusive rights with respect
to those lines.
2. Breeding quantities of the
Recurrent Parents of each of the DPL
Germplasm Lines identified in Table C,
subject to a license to Syngenta (a)
Permitting use of the Recurrent Parents
only for crossing or Backcrossing
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
between a Line and its relevant
Recurrent Parent; (b) requiring that the
Recurrent Parent Germplasm be
returned or destroyed no later than
December 31, 2014; and (c) prohibiting
transfer of the Recurrent Parent
Germplasm to any third party other than
with an exclusive license to the relevant
Line derived from that Recurrent Parent,
with the same limitations on use of the
Recurrent Parent Germplasm.
3. A non-exclusive royalty-free license
to a PCR assay and/or an ELISA assay
to enable detection of Monsanto’s
Roundup Ready Flex trait.
4. A non-exclusive license to (a)
Develop, produce, and sell cottonseed
containing the Roundup Ready Flex
trait under the standard commercial
terms offered by Defendant Monsanto,
including changes required by this
Decree to the standard license, and (b)
transfer such cottonseed to a third party
with a commercial Roundup Ready Flex
license.
PO 00000
Frm 00014
Fmt 4701
Sfmt 4703
5. Defendant DPL’s interest in
Germplasm populations Introgressed
with the Cry67B event, Cry69D event,
Cry02A event, and/or the Cot102 in the
U.S. cotton Breeding program that
Defendant DPL purchased from
Syngenta pursuant to an agreement
dated May 15, 2006, along with any
progeny of that material.
6. Defendant Monsanto may condition
the divestitures on Syngenta’s
acknowledgment that Defendant
Monsanto is not conveying to Syngenta
any rights not held by Defendant DPL
prior to Defendant Monsanto’s
acquisition of Defendant DPL.
7. Defendants acknowledge that
nothing in this Final Judgment relating
to the divestiture of the VipCot Assets
shall, in and of itself, modify, alter,
terminate or otherwise affect any rights
and obligations in any contract between
Syngenta and either of the Defendants
in effect as of the date of the filing of
the Complaint in this matter.
E:\FR\FM\15JNN2.SGM
15JNN2
V1C1RF
X
................
X
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
X
................
................
................
00H29 ......................................................
00S07 .......................................................
00W12 ......................................................
01W34 ......................................................
02T15 .......................................................
02Z55 .......................................................
02Z89 .......................................................
03H070 ....................................................
03Q066 ....................................................
03Y047 .....................................................
03Y056 .....................................................
03Y062 .....................................................
04P011 .....................................................
04P024 .....................................................
04Q035 ....................................................
04T042 .....................................................
04T048 .....................................................
04T056 .....................................................
04T067 .....................................................
04V073 .....................................................
04W019 ....................................................
04Y288 .....................................................
04Y341 .....................................................
04Z007 .....................................................
04Z353 .....................................................
05H210 ....................................................
05H229 ....................................................
05H270 ....................................................
05H284 ....................................................
05Q153 ....................................................
05T103 .....................................................
05V341 .....................................................
05X460 .....................................................
05Y063 .....................................................
05Y067 .....................................................
05Y070 .....................................................
05Z629 .....................................................
05Z855 .....................................................
25105N ....................................................
DP491 ......................................................
DP6207 ....................................................
SG747 ......................................................
UA–4 ........................................................
VerDate Aug<31>2005
................
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
................
X
X
X
V1C1
X
X
X
................
X
X
................
X
X
X
X
X
................
................
................
................
X
................
................
X
X
................
X
................
................
................
................
................
X
X
................
................
X
................
................
................
X
................
X
X
X
X
................
C1
................
X
X
X
X
X
................
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
................
X
................
X
X
X
................
X
X
X
................
................
................
X
X
................
X
................
X
................
V1
................
X
................
................
................
................
................
................
................
................
X
................
................
................
................
................
................
................
................
X
................
................
X
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
X
................
................
................
C1RF
................
................
X
X
................
X
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
X
................
................
................
V1RF
X
X
X
................
X
X
................
X
X
X
X
X
................
................
................
................
X
................
................
X
X
................
X
................
................
................
................
................
X
X
................
................
X
................
................
................
X
................
................
X
X
X
................
C2
X
X
X
................
X
X
................
X
X
X
X
X
................
................
................
................
X
................
................
X
X
................
X
................
................
................
................
................
X
X
................
................
X
................
................
................
X
................
................
X
X
X
................
C3
TABLE C—VIPCOT GERMPLASM
[V1 = Cot102; C1 = Cry67B; C2 = Cry69D, C3 =Cry02A; RF = Roundup Ready Flex]
Recurrent parent
rwilkins on PROD1PC63 with NOTICES2
X
................
X
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
X
................
................
................
C2V1RF
X
................
X
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
X
................
................
................
C3V1RF
................
................
X
................
X
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
X
X
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
X
................
X
................
C2V1
................
................
................
................
X
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
................
X
................
X
................
C3V1
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
20:04 Jun 14, 2007
Jkt 211001
PO 00000
Frm 00015
Fmt 4701
Sfmt 4703
E:\FR\FM\15JNN2.SGM
15JNN2
33349
33350
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
rwilkins on PROD1PC63 with NOTICES2
SCHEDULE D.—ADVANCED EXOTIC YIELD LINES
[The Lines identified by the following serial numbers or variety name in Defendant Monsanto’s Breeding database]
MCS0719B2RF
MSC0720B2RF
MCS0721B2RF
MCS0722B2RF
MCS0723B2RF
MCS0724B2RF
MCS0725B2RF
MCS0726B2RF
MCS0727B2RF
MCS0728B2RF
MCS0729RF
MCS0730RF
MCS0731RF
MCS0732RF
MCS0733RF
MCS0734RF
MCS0735RF
MCS0736RF
MCS0737RF
MCS0738RF
MCS0739RF
MCS0740RF
60066412443
60066412455
60066412532
60066412683
60066412859
60066403254
60066403367
60066403418
60067812303
60067812620
60067813494
60067813646
60067814903
60067815638
60067815791
60067816147
60067817050
60067818115
60067818571
60067819193
60067806259
60067806297
60067809534
60067809661
60067810676
60067810878
60067810979
60067810993
60067811185
60067813228
60067813444
60067814268
60067815296
60067815981
60067816058
60067816692
60067818711
60067819371
100000002189562355750000
100000002189564321830000
100000002189734715430000
100000002189736681510000
100000002189738647590000
100000002189739958310000
100000002189748477990000
100000002189751099430000
100000002189753720870000
100000002189757653030000
100000002189758963750000
100000002189766172710000
VerDate Aug<31>2005
20:04 Jun 14, 2007
60066403610
60066403634
60066404080
60066404181
60066404294
60066404395
60066404434
60066404446
60066404559
60066404840
60066405082
60066404207
60066405676
60066405703
60066406399
60066406515
60066407442
60066415021
60066415122
60066415285
60066407846
60066416124
60066408519
60066408608
60066408747
60066409129
60066409131
60066409220
60066409585
60066410350
100000002189566943270000
100000002189570220070000
100000002189570875430000
100000002189573496870000
100000002189575462950000
100000002189576118310000
100000002189580705830000
100000002189581361190000
100000002189586604070000
100000002189587259430000
100000002189591191590000
100000002189593157670000
100000002189597745190000
100000002189598400550000
100000002189600366630000
100000002189601677350000
100000002189604954150000
100000002189608230950000
100000002189614784550000
100000002189615439910000
100000002189616095270000
100000002189618716710000
100000002189620682790000
100000002189621338150000
100000002189623959590000
100000002189624614950000
100000002189629857830000
100000002189631168550000
100000002189637722150000
100000002189638377510000
100000002189642309670000
100000002189649518630000
100000002189819912230000
100000002189825155110000
100000002189829087270000
100000002189834330150000
100000002189836951590000
100000002189837606950000
100000002189839573030000
100000002189843505190000
100000002189844815910000
100000002189847437350000
Jkt 211001
PO 00000
Frm 00016
Fmt 4701
Sfmt 4703
60066410398
60066410475
60066410502
60066410552
60066410588
60066411326
60066411883
60066412001
60066412164
60066412380
60066414586
60066414649
60066406666
60066406767
60066407644
60066416821
60066409686
60066409701
60066410146
60067807314
60067807720
60067808924
60067809433
60067809774
60067810082
60067810208
60067810347
60067810501
60067811325
60067811642
100000002189651484710000
100000002189652140070000
100000002189654761510000
100000002189658038310000
100000002189659349030000
100000002189661315110000
100000002189664591910000
100000002189665247270000
100000002189669834790000
100000002189678354470000
100000002189679009830000
100000002189680975910000
100000002189682286630000
100000002189682286630000
100000002189683597350000
100000002189684908070000
100000002189686874150000
100000002189696704550000
100000002189699325990000
100000002189700636710000
100000002189709811750000
100000002189712433190000
100000002189714399270000
100000002189717020710000
100000002189718986790000
100000002189719642150000
100000002189720297510000
100000002189722263590000
100000002189725540390000
100000002189726195750000
100000002189730783270000
100000002189731438630000
100000002189914939430000
100000002189916905510000
100000002189917560870000
100000002189923459110000
100000002189926080550000
100000002189930012710000
100000002189932634150000
100000002189935910950000
100000002189936566310000
100000002189938532390000
E:\FR\FM\15JNN2.SGM
15JNN2
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
rwilkins on PROD1PC63 with NOTICES2
SCHEDULE D.—ADVANCED EXOTIC YIELD LINES—Continued
[The Lines identified by the following serial numbers or variety name in Defendant Monsanto’s Breeding database]
100000002189769449510000
100000002189772070950000
100000002189773381670000
100000002189776003110000
100000002189778624550000
100000002189781901350000
100000002189784522790000
100000002189787144230000
100000002189790421030000
100000002189792387110000
100000002189794353190000
100000002189798285350000
100000002189798940710000
100000002189800251430000
100000002189801562150000
100000002189803528230000
100000002189805494310000
100000002189806149670000
100000002189808771110000
100000002189812047910000
100000002189815980070000
100000002189816635430000
100000002190036683630000
100000002190038147110000
100000002190038802470000
100000002190040113190000
100000002190048632870000
100000002190054531110000
100000002190055841830000
100000002190059773990000
100000002190061084710000
100000002190065672230000
100000002190066327590000
100000002190075502630000
100000002190076157990000
100000002190082056230000
100000002190086643750000
100000002190089920550000
100000002190091886630000
100000002190097129510000
100000002190099750950000
100000002190101717030000
100000002190104993830000
100000002190110236710000
100000002190110892070000
100000002190113513510000
100000002190115479590000
100000002190118101030000
100000002190123343910000
100000002190123999270000
100000002190127276070000
100000002190127931430000
100000002190133174310000
100000002190137106470000
100000002190371069990000
100000002190377623590000
100000002190378278950000
100000002190380900390000
100000002190384832550000
100000002190385487910000
100000002190387453990000
100000002190388109350000
100000002190393352230000
100000002190394007590000
100000002190396629030000
100000002190398595110000
100000002190399905830000
100000002190401871910000
100000002190403182630000
100000002190406459430000
100000002190407114790000
100000002190409080870000
100000002190411702310000
VerDate Aug<31>2005
20:04 Jun 14, 2007
100000002189853335590000
100000002189853990950000
100000002189855957030000
100000002189857267750000
100000002189862510630000
100000002189865132070000
100000002189867098150000
100000002189870374950000
100000002189876273190000
100000002189876928550000
100000002189880860710000
100000002189885448230000
100000002189887414310000
100000002189888725030000
100000002189891346470000
100000002189894623270000
100000002189897244710000
100000002189897900070000
100000002189899210790000
100000002189901176870000
100000002189912973350000
100000002189914284070000
100000002190144970790000
100000002190150213670000
100000002190150869030000
100000002190152835110000
100000002190161354790000
100000002190162010150000
100000002190167908390000
100000002190171840550000
100000002190175117350000
100000002190177738790000
100000002190181670950000
100000002190187569190000
100000002190190190630000
100000002190192156710000
100000002190192812070000
100000002190193467430000
100000002190196088870000
100000002190196744230000
100000002190212472870000
100000002190213128230000
100000002190215749670000
100000002190220337190000
100000002190223613990000
100000002190225580070000
100000002190232789030000
100000002190234099750000
100000002190238687270000
100000002190239979990000
100000002190245896230000
100000002190247206950000
100000002190256381990000
100000002190257692710000
100000002190460198950000
100000002190463475750000
100000002190470029350000
100000002190471340070000
100000002190471995430000
100000002190474616870000
100000002190478549030000
100000002190481825830000
100000002190482481190000
100000002190486413350000
100000002190489690150000
100000002190491656230000
100000002190493622310000
100000002190494933030000
100000002190500175910000
100000002190501486630000
100000002190503452710000
100000002190508040230000
100000002190511317030000
Jkt 211001
PO 00000
Frm 00017
Fmt 4701
Sfmt 4703
100000002189943119910000
100000002189945085990000
100000002189947707430000
100000002189949018150000
100000002189952294950000
100000002189954261030000
100000002189958848550000
100000002189960159270000
100000002189962780710000
100000002189970645030000
100000002189976543270000
100000002189979820070000
100000002189983752230000
100000002190001446950000
100000002190005379110000
100000002190009311270000
100000002190015209510000
100000002190019141670000
100000002190020452390000
100000002190021763110000
100000002190027661350000
100000002190029627430000
100000002190264246310000
100000002190268178470000
100000002190268833830000
100000002190270144550000
100000002190275387430000
100000002190276042790000
100000002190277353510000
100000002190279974950000
100000002190281285670000
100000002190286528550000
100000002190293082150000
100000002190298325030000
100000002190298980390000
100000002190302912550000
100000002190304223270000
100000002190308155430000
100000002190312087590000
100000002190316675110000
100000002190319296550000
100000002190320607270000
100000002190325194790000
100000002190327816230000
100000002190328471590000
100000002190330437670000
100000002190331093030000
100000002190336991270000
100000002190338301990000
100000002190339612710000
100000002190340268070000
100000002190345793190000
100000002190366482470000
100000002190367779310000
100000002190547361830000
100000002190548017190000
100000002190553915430000
100000002190557847590000
100000002190561779750000
100000002190563090470000
100000002190565711910000
100000002190567022630000
100000002190570954790000
100000002190571610150000
100000002190576853030000
100000002190582095910000
100000002190582751270000
100000002190583406630000
100000002190584061990000
100000002190584717350000
100000002190592581670000
100000002190593892390000
100000002190597824550000
E:\FR\FM\15JNN2.SGM
15JNN2
33351
33352
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
rwilkins on PROD1PC63 with NOTICES2
SCHEDULE D.—ADVANCED EXOTIC YIELD LINES—Continued
[The Lines identified by the following serial numbers or variety name in Defendant Monsanto’s Breeding database]
100000002190414979110000
100000002190415634470000
100000002190422188070000
100000002190431363110000
100000002190432673830000
100000002190433329190000
100000002190433984550000
100000002190435950630000
100000002190439882790000
100000002190449713190000
100000002190451023910000
100000002190454300710000
100000002190455611430000
100000002190633213990000
100000002190637146150000
100000002190638456870000
100000002190643044390000
100000002190646976550000
100000002190649597990000
100000002190650253350000
100000002190653530150000
100000002190654185510000
100000002190654840870000
100000002190655496230000
100000002190656151590000
100000002190656806950000
100000002190658773030000
100000002190659428390000
100000002190664015910000
100000002190665326630000
100000002190670569510000
100000002190675157030000
100000002190676467750000
100000002190677778470000
100000002190678433830000
100000002190679089190000
100000002190681055270000
100000002190682365990000
100000002190688264230000
100000002190689574950000
100000002190696128550000
100000002190700716070000
100000002190703992870000
100000002190706614310000
100000002190712512550000
100000002190871109670000
100000002190871765030000
100000002190873075750000
100000002190873731110000
100000002190876352550000
100000002190877007910000
100000002190878318630000
100000002190878973990000
100000002190880284710000
100000002190884216870000
100000002190884872230000
100000002190887493670000
100000002190888804390000
100000002190903877670000
100000002190905843750000
100000002190909120550000
P00000000000123713880509
P00000000000123717091773
P00000000000123718795709
P00000000000123724497341
60044433150
60035225881
60043573686
VerDate Aug<31>2005
20:04 Jun 14, 2007
100000002190513283110000
100000002190514593830000
100000002190520492070000
100000002190522458150000
100000002190523768870000
100000002190524424230000
100000002190525079590000
100000002190527045670000
100000002190533599270000
100000002190536220710000
100000002190538186790000
100000002190540152870000
100000002190545395750000
100000002190717755430000
100000002190719721510000
100000002190725619750000
100000002190726275110000
100000002190728241190000
100000002190729551910000
100000002190730862630000
100000002190734139430000
100000002190734794790000
100000002190740037670000
100000002190744625190000
100000002190745935910000
100000002190747901990000
100000002190749868070000
100000002190751178790000
100000002190752489510000
100000002190757077030000
100000002190759043110000
100000002190761009190000
100000002190762319910000
100000002190763630630000
100000002190764285990000
100000002190764941350000
100000002190769528870000
100000002190774116390000
100000002190780669990000
100000002190782636070000
100000002190785257510000
100000002190789189670000
100000002190789845030000
100000002190793777190000
100000002190798364710000
100000002190909775910000
100000002190913052710000
100000002190914363430000
100000002190915674150000
100000002190917640230000
100000002190920917030000
100000002190922883110000
100000002190923538470000
100000002190926815270000
100000002190929436710000
100000002190932713510000
100000002190933368770000
100000002190934679590000
100000002190937301030000
100000002190945165350000
100000002190953029670000
P00000000000123714666941
P00000000000123717419453
P00000000000123720630717
P00000000000123726856637
60035225831
60035225906
Jkt 211001
PO 00000
Frm 00018
Fmt 4701
Sfmt 4703
100000002190598479910000
100000002190602412070000
100000002190603067430000
100000002190603722790000
100000002190612242470000
100000002190620106790000
100000002190620762150000
100000002190622072870000
100000002190623383590000
100000002190627315750000
100000002190627971110000
100000002190629281830000
100000002190631903270000
100000002190801641510000
100000002190802952230000
100000002190804262950000
100000002190805573670000
100000002190812782630000
100000002190818680870000
100000002190821957670000
100000002190823268390000
100000002190823923750000
100000002190824579110000
100000002190825234470000
100000002190826545190000
100000002190829821990000
100000002190833098790000
100000002190837686310000
100000002190840963110000
100000002190841618470000
100000002190847516710000
100000002190848172070000
100000002190849482790000
100000002190854070310000
100000002190854725670000
100000002190856036390000
100000002190856691750000
100000002190858002470000
100000002190859313190000
100000002190859968550000
100000002190861279270000
100000002190861934630000
100000002190865866790000
100000002190866522150000
100000002190867177510000
100000002190954340390000
100000002190959583270000
100000002190963515430000
100000002190966136870000
100000002190966792230000
100000002190973345830000
100000002190975967270000
100000002190978588710000
100000002190981865510000
100000002190982520870000
100000002190985142310000
ICA000000003347367788989
ICA000000003347473105341
ICA000000003347683279293
ICA000000003348103168445
P00000000000123710341565
P00000000000123714994621
P00000000000123717943741
P00000000000123722662333
P00000000000123727184317
60035225879
60035225920
E:\FR\FM\15JNN2.SGM
15JNN2
33353
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
SCHEDULE E.—MAB POPULATIONS
[The Lines identified by the following code numbers in Defendant Monsanto’s Breeding database]
L0001
L0002
L0003
L0004
L0005
L0006
L0007
L0008
L0009
L0010
L0012
L0013
L0014
L0015
L0016
L0017
L0018
L0019
L0020
L0021
L0022
L0023
L0024
L0025
L0027
L0028
L0029
L0030
L0031
L0032
L0033
L0034
L0035
L0036
L0037
L0038
L0039
L0040
L0041
L0042
L0043
L0044
L0045
L0046
L0047
L0048
L0049
L0050
L0051
L0052
L0053
L0054
L0055
L0056
L0057
L0059
L0100
L0175
L0224
L0225
L0226
L0227
L0228
L0229
L0230
L0231
L0232
L0233
L0234
L0235
L0236
L0237
L0238
L0239
L0240
L0241
L0242
L0243
L0244
L0245
L0246
L0247
L0248
L0249
L0250
L0251
L0252
L0253
L0254
L0255
L0256
L0257
Schedule F—Donor Lines
MON 531 in Coker 312
MON 757 in any variety
MON 1445 in Coker 312
MON 1698 in any variety
MON 15985 in DP50B or PS7
MON 88913 in Coker 130, PS7 or
Suregro 125
MON 15985 x MON 88913 in PS7 or
Suregro 125
MON 1076 in any variety
MON 15947 in any variety
United States District Court for the
District of Columbia
United States of America, Plaintiff, v.
Monsanto Company and Delta and Pine
Land Company, Defendants.
Case: 1:07–cv–00992.
Assigned To: Urbina, Ricardo M.
Assign Date: 5/31/2007.
Description: Antitrust.
Competitive Impact Statement
Plaintiff United States of America
(‘‘United States’’), pursuant to Section
2(b) of the Antitrust Procedures and
Penalties Act (‘‘APPA’’ or ‘‘Tunney
Act’’), 15 U.S.C. 16(b)–(h), files this
Competitive Impact Statement relating
to the proposed Final Judgment
submitted for entry in this civil antitrust
proceeding.
rwilkins on PROD1PC63 with NOTICES2
I. Nature and Purpose of the Proceeding
Defendants entered into an Agreement
and Plan of Merger dated August 14,
2006, pursuant to which Monsanto
Company (‘‘Monsanto’’) will acquire
Delta and Pine Land Company (‘‘DPL’’).
The United States filed a civil antitrust
Complaint on May 31, 2007, seeking to
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
L0271
L0282
L0283
L0284
L0290
L0291
L0292
L0293
L0294
L0295
L0296
L0297
L0298
L0299
L0301
L0302
L0303
L0304
L0305
L0306
L0307
L0308
L0309
L0310
L0311
L0312
L0313
L0314
L0315
L0317
L0318
L0319
L0320
L0321
L0322
L0323
L0324
L0325
L0326
L0327
L0328
L0329
L0330
L0331
L0332
L0333
L0334
L0335
L0336
L0337
L0338
L0339
L0340
L0341
L0342
L0343
L0344
L0345
L0346
L0347
L0348
L0349
L0350
L0351
L0352
L0353
L0354
L0355
L0356
enjoin the proposed acquisition. The
Complaint alleges that the likely effect
of this acquisition would be to
substantially lessen competition in the
market for the development, production,
and sale of traited cottonseed—
cottonseed genetically modified to
contain desirable characteristics from
non-cottonseed sources—in violation of
Section 7 of the Clayton Act, 15 U.S.C.
18. This loss of competition would
likely result in higher prices and fewer
choices for cotton farmers in the
MidSouth (Mississippi, Arkansas,
Louisiana, Missouri, and Tennessee)
and Southeast (Alabama, Georgia,
Florida, North Carolina, South Carolina,
and Virginia).
At the same time the Complaint was
filed, the United States also filed a Hold
Separate and Preservation of Assets
Stipulation and Order (‘‘Hold Separate’’)
and proposed Final Judgment, which
are designed to eliminate the anti
competitive effects of the acquisition.
Under the proposed Final Judgment,
which is explained more fully below, (1)
Defendants must divest Stoneville
Pedigreed Seed Company
(‘‘Stoneville’’), certain cottonseed lines
developed by DPL for the MidSouth and
Southeast, and additional cotton
breeding assets of Monsanto
(collectively, the ‘‘Enhanced Stoneville
Assets’’) to an acquirer or acquirers
acceptable to the United States; (2)
Defendants must divest to Syngenta
Crop Protection AG (‘‘Syngenta’’) fortythree DPL cottonseed lines containing
Vip Cot, Syngenta’s insect-resistant trait
technology that DPL was developing for
cottonseed (the ‘‘VipCot Assets’’); and
PO 00000
Frm 00019
Fmt 4701
Sfmt 4703
L0357
L0358
L0359
L0360
L0361
L0362
L0363
L0364
L0365
L0366
L0367
L0368
L0369
L0370
L0371
L0372
L0373
L0374
L0375
L0376
L0377
L0378
L0379
L0380
L0381
L0382
L0383
L0384
L0385
L0386
L0387
L0388
L0390
L0391
L0392
L0393
L0394
L0395
L0396
L0397
L0398
L0399
L0400
L0401
L0402
L0403
L0404
L0406
L0407
L0408
L0409
L0410
L0411
L1002
L1003
L1004
L1005
L1008
L1009
(3) Defendant Monsanto must modify its
cottonseed trait licenses with seed
companies to permit licensees to breed
and sell, without penalty, cottonseed
containing non-Monsanto traits and
cottonseed containing both licensed
Monsanto traits and non-Monsanto
traits, and modify its Cotton States
licenses to remove any provision that
allows Monsanto to terminate the
license if the licensee sells cottonseed
containing other traits.
Until the divestiture of the Enhanced
Stoneville Assets has been
accomplished, the Hold Separate
requires Defendants to take all steps
necessary to ensure that DPL is operated
as an independent, ongoing,
economically viable competitive
business held entirely separate, distinct
and apart from Monsanto’s commercial
operations. The proposed Final
Judgment provides that if the Enhanced
Stoneville Assets are not sold within the
time period prescribed in the proposed
Final Judgment to an acquirer or
acquirers acceptable to the United
States, Monsanto will divest DPL.
The Hold Separate also requires
Defendants to preserve the divestiture
assets. Until the divestiture of the
Enhanced Stoneville Assets, Defendants
must take all steps necessary to ensure
that Stoneville will be maintained and
operated as an ongoing, economically
viable and active competitor in the
development, production, and sale of
traited cottonseed. Until the divestiture
of the VipCot Assets has been
accomplished, Defendants must
preserve the VipCot Assets and use all
reasonable efforts to proceed with their
E:\FR\FM\15JNN2.SGM
15JNN2
33354
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
development, including maintaining all
production processes for the assets, so
as not to unduly delay the
commercialization and sale of
cottonseed containing VipCot in the
United States.
The settlement ensures the
continuation of current competition in
the MidSouth and Southeast between
Stoneville and DPL. It also preserves
Syngenta’s ability to bring cottonseed
with VipCot to the market with minimal
delay. And, it provides trait developers
a seed company independent of
Monsanto offering a platform of highquality germplasm for the development
of non-Monsanto traited cottonseed for
the MidSouth and Southeast, preserving
the prospects for trait competition in
cottonseed.
The United States and Defendants
have stipulated that the proposed Final
Judgment may be entered after
compliance with the APPA. Entry of the
proposed Final Judgment would
terminate this action, except that the
Court would retain jurisdiction to
construe, modify, or enforce the
provisions of the proposed Final
Judgment and to punish violations
thereof.
rwilkins on PROD1PC63 with NOTICES2
II. Description of the Events Giving Rise
to the Alleged Violation
A. The Defendants and the Proposed
Transaction
Defendant Monsanto is a Delaware
corporation with its headquarters in St.
Louis, Missouri. Monsanto is a leading
global provider of agricultural products
for farmers, including seeds for cotton,
soybeans, and corn; in-the-seed trait
technologies that protect crops against
damage from insects and weeds; and
crop protection chemicals such as the
herbicide Roundup. Monsanto’s total
revenues in 2006 exceeded $7.3 billion.
The vast majority of cotton grown in the
U.S. contains biotech traits, and over
96% of the traited cottonseed sold
domestically contains Monsanto traits.
Monsanto’s two groups of cottonseed
traits are marketed under the brand
names (a) Roundup Ready, and its
successor Roundup Ready Flex, both of
which make cotton resistant to harm
from glyphosate-based herbicides like
Monsanto’s Roundup, and (b) Bollgard,
and its successor Bollgard II, both of
which make cotton plants toxic to
lepidopteran insect pests such as the
cotton bollworm. Monsanto licenses its
traits to seed companies, including DPL.
Monsanto’s cottonseed sales,
primarily through its Stoneville
subsidiary, account for approximately
16% of the traited cottonseed sold in the
United States in 2006, making Monsanto
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
one of the largest sellers of traited
cottonseed in the United States. In the
MidSouth and Southeast, Monsanto
accounted for 17% and 8%,
respectively, of all traited cottonseed
sales.
Defendant DPL is a Delaware
corporation with its headquarters in
Scott, Mississippi. DPL is the largest
supplier of traited cottonseed in the
United States. In 2006, DPL accounted
for approximately 56% of the traited
cottonseed sold in the United States,
with sales exceeding $417 million. In
the MidSouth and Southeast, DPL
accounted for 79% and 87%,
respectively, of all traited cottonseed
sales. DPL does not itself produce traits,
but works with biotechnology
companies to develop cottonseed traits
and to breed the resulting traits into
DPL germplasm (the genetic material
containing the inherent qualities of
cottonseed, such as yield and fiber
quality).
The combination of Monsanto and
DPL would create the largest provider of
traited cottonseed in the United States
and give the combined firm about 95%
of traited cottonseed sales in the
MidSouth and Southeast. The proposed
transaction would also eliminate DPL as
a partner independent of Monsanto for
competing trait developers, thereby
substantially delaying or preventing the
development and introduction of
cottonseed containing non-Monsanto
traits. Thus, the proposed transaction
would lessen competition substantially
in violation of Section 7 of the Clayton
Act.
B. The Cotton Industry
Cotton is currently grown on over
fifteen million acres in the United
States, in seventeen states across the
Southern United States from Virginia to
California. The industry recognizes four
distinct growing regions: the MidSouth,
Southeast, Southwest (Texas, Kansas,
and Oklahoma), and West (Arizona,
New Mexico, and California). The
cottonseed varieties grown vary by
region because growing conditions, such
as soil type and climate, affect seed
performance. Farmers choose
cottonseed varieties that perform best in
their geographic area, placing the
greatest emphasis on a variety’s yield
(i.e., the expected amount of cotton
produced per acre).
Cottonseed companies continually
work on developing improved
cottonseed varieties through their
breeding programs. Cotton breeding is a
costly and time-consuming process in
which the cottonseed company selects
lines to breed together (or ‘‘cross’’),
plants cottonseed generated by that
PO 00000
Frm 00020
Fmt 4701
Sfmt 4703
initial cross, and then selects the best
plants for further crossing to create a
variety with the desired characteristics.
In most cases, it takes eight to ten years
from the initial cross until a new
conventional cottonseed variety (i.e.,
seed containing no transgenic traits) is
ready for market, while a traited version
of that same conventional variety may
take an additional two to three years.
The success of a cottonseed
company’s breeding program is
dependent on many factors, the most
important of which are the quantity and
quality of available breeding materials,
i.e., germplasm. A company with a large
collection of high-quality, or elite,
germplasm has a significant advantage
because it is able to identify the best
genetic material and use it in a wide
variety of possible crossing
combinations, resulting in a greater
likelihood of developing a successful
variety.
1. The Development of Traited
Cottonseed
Monsanto and DPL partnered in the
1980s to develop and produce traited
cottonseed. DPL contributed its highquality germplasm and experienced
cotton breeders; Monsanto, its insectresistant and herbicide-tolerant traits. In
1996, DPL began to sell the first
cottonseed with Monsanto’s insectresistant trait (Bollgard) and, the
following year, introduced a variety
with Monsanto’s herbicide-tolerant trait
(Roundup Ready).
Farmers quickly adopted Monsantotraited cottonseed because its use
significantly lowered fanning costs and
reduced the risk of crop loss. Farming
with conventional seed involved laborintensive, costly herbicide and
insecticide applications at specific times
in the growing season. Farmers had to
target herbicide applications only on
weeds to avoid killing the cotton plants.
By planting cottonseed containing an
herbicide-tolerant trait, such as
Roundup Ready, farmers can spray
herbicide over the entire crop to kill
weeds without killing the young cotton
plants. Cottonseed containing an insectresistant trait, such as Bollgard, reduces
insecticide purchases and spraying.
Today, almost all of the cottonseed
planted in the MidSouth and Southeast,
where insects and weeds pose
significant problems, contains traits that
provide both insect resistance and
herbicide tolerance.
When farmers acquire traited
cottonseed, they pay a price per bag to
the seed distributor, who, in turn, pays
the seed manufacturer (e.g., DPL) for the
seed and a separate license fee to the
developer of the trait (e.g., Monsanto).
E:\FR\FM\15JNN2.SGM
15JNN2
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
rwilkins on PROD1PC63 with NOTICES2
This license fee, commonly referred to
as the ‘‘technology fee,’’ is usually
collected by the seed distributor for the
trait developer. Typically, the trait
developer shares a portion of the
technology fee with the seed distributor
and the seed manufacturer. The
technology fee can constitute as much
as 80% of farmers’ total costs for a bag
of traited cottonseed.
Only two non-Monsanto cotton traits
are currently commercialized.
WideStrike is an insect-resistant trait
developed by Dow AgroSciences to
compete with Monsanto’s Bollgard trait.
WideStrike is only available in Dow’s
Phytogen cottonseeds, which are
primarily used in California where they
perform well. LibertyLink, a trait
developed by Bayer CropScience to
make cotton tolerant to glufosinate
herbicides, competes with Monsanto’s
Roundup Ready glyphosate herbicidetolerant trait. LibertyLink is only
available in Bayer’s FiberMax
cottonseeds, which are primarily used
in the Southwest where they perform
well. Together, cottonseed containing
WideStrike or LibertyLink accounted for
less than 5% of total United States
traited cottonseed sales in 2006.
2. DPL’s Trait Development With
Monsanto’s Competitors
After a failed attempt to merge with
Monsanto in the late 1990s, DPL
commenced a strategy to replace (or
‘‘trade-out’’) the Monsanto traits in DPL
cottonseed with traits developed by
Monsanto’s competitors. DPL has
worked with several biotechnology
companies, including Syngenta,
DuPont, Bayer, and Dow, to develop
cottonseed containing the traits
developed by these companies that
would compete with cottonseed
containing Monsanto traits.
The process to develop a cotton trait
and breed and commercialize
cottonseed varieties with that trait
typically takes eight to twelve years and
costs over $100 million. The process
often requires thousands of attempts
before developing a traited cottonseed
that can be used to breed commercial
varieties. In addition, extensive
regulatory approvals, both in the United
States and abroad, are required.
Trait developers consider DPL an
attractive partner for two reasons. First,
DPL is in a strong position to introduce
new trait technologies due to its
extensive breeding programs, elite
germplasm collection, technical service
capabilities, know-how, brand
recognition, and market position.
Second, DPL’s trait licenses with
Monsanto allow DPL to offer competing
trait developers the ability to combine
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
or ‘‘stack’’ their traits in DPL cottonseed
with Monsanto traits. This stacking right
would allow, for example, the developer
of an insect-resistant trait to bring that
trait to market in cottonseed that also
contains Monsanto’s Roundup Ready (or
Roundup Ready Flex) herbicide-tolerant
trait. Most United States farmers choose
cottonseed that contains both an insectresistant trait and an herbicide-tolerant
trait. Monsanto’s trait licenses with
cottonseed companies other than DPL
severely restrict the ability of those
companies to work with other trait
developers, with some licenses
prohibiting stacking of Monsanto’s traits
with another company’s traits.
DPL’s most advanced work with nonMonsanto trait developers is with
Syngenta. DPL’s developmental work
with Syngenta resulted in a 2004
agreement to commercialize cottonseed
with Syngenta’s VipCot insect-resistant
traits. VipCot has been incorporated into
some of DPL’s best germplasm, and DPL
had expected, before Monsanto’s
proposed acquisition was announced, to
begin marketing such cottonseed as
early as 2009.
Monsanto’s Cottonseed Business
Facing DPL’s strategy to replace
Monsanto traits in DPL seed with traits
developed by Monsanto’s competitors,
Monsanto set about building its own
cottonseed business to compete
vigorously against DPL. Pursuant to this
strategy, Monsanto began its Cotton
States program in early 2002. Through
Cotton States, Monsanto obtains
licenses for cotton germplasm that small
seed companies, private breeders and
universities have developed; improves
the germplasm through selective
breeding; introduces Monsanto traits;
and out-licenses the resulting traited
cottonseed varieties to distributors and
small cottonseed companies for sale
under private labels.
In 2005, Monsanto repurchased
Stoneville, the second-largest traited
cottonseed company in the MidSouth
and Southeast. (Monsanto had
previously purchased Stoneville in
1996, and sold it in 1999 shortly before
abandoning its attempt to acquire DPL.)
Upon reacquiring Stoneville, Monsanto
immediately invested capital to improve
Stoneville’s competitive position. With
the acquisition of Stoneville, Monsanto
became the second largest seller of
traited cottonseed in the important
MidSouth and Southeast regions.
Monsanto aggressively worked to
strengthen its cottonseed business by,
among other things, focusing on
advanced breeding techniques and
germplasm development and investing
in breeding facilities. Monsanto
PO 00000
Frm 00021
Fmt 4701
Sfmt 4703
33355
predicted internally that these
investments would enable Monsanto to
increase its share of the cottonseed
business in competition with DPL.
C. Product and Geographic Markets
The relevant antitrust product and
geographic markets are the
development, commercialization, and
sale of traited cottonseed for the
MidSouth and Southeast. Growing
conditions for cotton differ across
regions due to weather conditions, soil
type, and varied demands for weed and
insect control. Farmers demand
cottonseed varieties that produce high
yield for their particular growing
conditions. Monsanto and DPL
recognize this demand and market
cottonseed varieties by region.
In many regions of the country,
particularly the MidSouth and
Southeast, farmers demand that
cottonseed have traits that provide
insect resistance and herbicide
tolerance. In the MidSouth and
Southeast, approximately 90% of traited
seed purchased by farmers contains
both types of traits. Monsanto prices
traits by region.
Cotton is a particularly high-value
crop in the MidSouth and Southeast,
where over 50% of domestic cotton is
grown. The cost of cottonseed amounts
to only a fraction of the total cost of
growing cotton. A small but significant
increase in the price of traited
cottonseed in the MidSouth and
Southeast regions would not cause
sufficient farmers to plant other crops,
or switch sufficient cottonseed
purchases to conventional (non-traited)
cottonseed or cottonseed varieties not
well suited for their regions to make the
price increase unprofitable.
D. The Competitive Effects of the
Transaction on the Market for the
Development, Production, and Sale of
Traited Cottonseed in the MidSouth and
Southeast
Monsanto’s acquisition of DPL would
substantially lessen competition for the
development, commercialization, and
sale of traited cottonseed in the
MidSouth and Southeast. First, the
combination would increase the merged
firm’s ability and incentive to raise
prices and reduce choices for traited
cottonseed in the MidSouth and
Southeast. In the MidSouth, DPL and
Stoneville account for approximately
79% and 16%, respectively, of traited
cottonseed sales. In the Southeast, DPL
and Stoneville account for
approximately 87% and 8%,
respectively, of traited cottonseed sales.
After the proposed acquisition, the
combined Monsanto and DPL would
E:\FR\FM\15JNN2.SGM
15JNN2
33356
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
have a market share of approximately
95% for traited cottonseed sales in both
the MidSouth and Southeast.1
Second, the merger would eliminate
DPL as a partner independent of
Monsanto for developers of cotton traits
that would compete against Monsanto’s
traits. Syngenta’s current efforts to
develop and commercialize with DPL
cottonseed with Syngenta’s VipCot
insect-resistant technology to compete
with Monsanto’s Bollgard traits would
be substantially delayed or prevented,
preserving Monsanto’s current
dominance. And, the merger would
likely delay, if not deter, efforts to
develop other traits that would provide
benefits to United States cotton farmers,
including herbicide-tolerant traits that
would compete with Monsanto’s
Roundup Ready traits. As a result,
farmers likely would have fewer choices
of, and face higher prices for, traited
cottonseed.
E. Entry
Entry into the traited cottonseed
business would be difficult, time
consuming, and expensive. It requires
the assets and expertise both to breed
high-performing varieties of cottonseed
and to develop or obtain traits providing
insect resistance and herbicide
tolerance. For a company that has
developed a trait, de novo entry to
develop, breed, and commercialize
cottonseed varieties with the trait takes
approximately twelve years, costs
millions of dollars, requires a sufficient
supply of high-quality germplasm, and
is uncertain. Therefore, entry into the
traited cottonseed business would not
be timely, likely, or sufficient in its
magnitude, character, and scope to deter
or counteract an anticompetitive
increase in the price of traited
cottonseed by a combined Monsanto
and DPL.
rwilkins on PROD1PC63 with NOTICES2
III. Explanation of the Proposed Final
Judgment
The proposed Final Judgment
remedies the anticompetitive effects of
the acquisition alleged in the
Complaint—the elimination of
competition between DPL and
Monsanto for the development,
breeding, and sale of traited cottonseed
and the elimination of DPL as a partner
independent of Monsanto for developers
1 The MidSouth and Southeast traited cottonseed
markets are highly concentrated. As measured by
the Herfindahl-Hirschman Index (‘‘HHI’’), which is
commonly used in merger analysis and explained
in Appendix A of the Complaint, Monsanto’s
acquisition of DPL would increase the HHI by 3310
in the MidSouth, resulting in a postmerger HHI of
9110. In the Southeast, the proposed acquisition
would increase the HHI by 1489, resulting in a
postmerger HHI of 9184.
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
of traits that would compete against
Monsanto—by requiring Defendants to
divest the Enhanced Stoneville Assets to
an approved acquirer, to divest to
Syngenta over forty DPL cottonseed
breeding lines containing VipCot, and to
make certain licensing term
modifications to Monsanto’s Cotton
States and seed company licenses.
Taken together, these provisions will
preserve existing competition in the
market for traited cottonseed in the
MidSouth and Southeast, will allow
Syngenta to market cottonseed with
VipCot with no more than minimal
delay, and will ensure the continued
presence of a cottonseed company
independent of Monsanto with
sufficient germplasm and breeding
capabilities to serve as an effective
platform for development of cottonseed
traits in competition with Monsanto.
The proposed Final Judgment and its
accompanying schedules set forth the
specific assets to be divested (including
certain limitations to the assets being
divested), the modifications that
Defendant Monsanto must make to its
third-party licenses, and the other
obligations of Defendants. The following
describes these remedy provisions:
A. The Enhanced Stoneville Assets
The Enhanced Stoneville Assets
consist of Monsanto’s Stoneville
business, promising Monsanto
cottonseed germplasm, and twenty lines
of elite DPL germplasm, including a
dozen of DPL’s most promising
developmental lines for the MidSouth
and Southeast as well as Delta Pearl, the
parent of DPL’s highly-popular DPL555
variety. The proposed Final Judgment
requires Defendants to divest the
Enhanced Stoneville Assets to an
acquirer acceptable to the United States
in its sole discretion. The acquirer must
have a credible commitment to the
traited cottonseed market and have the
intent and capability of competing
effectively in the market. The
Defendants must divest the assets in
such a way as to satisfy the United
States, in its sole discretion, that the
assets can and will be used by the
acquirer as part of a viable, ongoing
business engaged in the development,
production, and sale of traited
cottonseed. These provisions are
designed to ensure that the Enhanced
Stoneville Assets will be used to
preserve competition that would
otherwise be lost as a result of the
acquisition.
This divestiture will provide the
acquirer of the Enhanced Stoneville
Assets the tools it needs—including
valuable germplasm from Stoneville,
Monsanto and DPL—to be a viable and
PO 00000
Frm 00022
Fmt 4701
Sfmt 4703
active competitor in the MidSouth and
Southeast, restoring the traited
cottonseed competition that would
otherwise be lost as a result of the
acquisition. The Enhanced Stoneville
Assets will provide the acquirer a
significant base of current and
developmental varieties that would be
attractive to trait developers looking to
introduce traits into cottonseed,
particularly cottonseed well suited to
the MidSouth and Southeast. The
remedy in the proposed Final Judgment
will give the acquirer capabilities that
exceed those of Stoneville and a
foundation on which to replicate the
platform for trait development and
commercialization that DPL previously
provided.
The Enhanced Stoneville Assets
include:
1. Stoneville
Defendants will divest Monsanto’s
U.S. Stoneville business, including all
U.S. Stoneville cotton germplasm. This
divestiture will give the acquirer the
benefit of Stoneville’s existing presence
in the MidSouth and its germplasm
development pipeline, which includes
approximately 35 mid-to-full- and fullseason lines for potential
commercialization in the MidSouth and
Southeast between 2008 and 2012. The
divestiture will also include Stoneville’s
breeding facilities, tangible assets, brand
names, breeder records and other
intangible assets.
The proposed Final Judgment also
requires Monsanto to grant the acquirer
licenses to Monsanto’s current Roundup
Ready and Bollgard traits on terms at
least as favorable as DPL’s current terms
with respect to stacking rights, revenue
sharing, and options for licensing future
traits. This licensing requirement will
provide the acquirer of Stoneville the
same ability as DPL to offer other trait
developers a platform upon which to
stack non-Monsanto traits with
Monsanto traits.
2. Additional Monsanto Cotton
Germplasm
Divesting Stoneville by itself would
not fully restore the lost competition
between Monsanto and DPL as it would
fail to capture the breadth of Monsanto’s
cotton breeding program that supported
Monsanto’s projected share growth. In
addition to Monsanto’s improvements to
Stoneville (which included adding a
breeding station and personnel),
Monsanto worked on advanced breeding
techniques and germplasm development
to strengthen its future competitive
position. The proposed Final Judgment
requires Monsanto to divest the
germplasm and technology related to
E:\FR\FM\15JNN2.SGM
15JNN2
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
rwilkins on PROD1PC63 with NOTICES2
these programs, as described below. As
some of this work was undertaken in
connection with Monsanto’s trait
development efforts, the proposed Final
Judgment allows Monsanto to retain
assets (and research rights to
germplasm) that directly relate to trait
development.
Advanced Exotic Yield Lines:
Defendants will divest the exclusive
right to commercialize varieties from the
Advanced Exotic Yield Lines set forth in
Schedule D of the proposed Final
Judgment. Monsanto developed this
germplasm as part of its ongoing nontransgenic yield trait discovery project,
which seeks to discover traits in exotic
cotton plants that could be bred into
commercial varieties to increase yield.
This project has resulted in the creation
of promising developmental germplasm
lines. Monsanto anticipated that
varieties developed from these lines
would be well suited for the MidSouth
and Southeast and could be introduced
as early as 2009. The acquirer will be
able to commercialize such varieties and
use the lines for additional breeding. As
these lines were part of Monsanto’s
ongoing trait research project, Monsanto
will be allowed to obtain a license back
from the acquirer to continue to use
these lines for that research effort.
Marker Assisted Breeding (‘‘MAB’’)
Populations: Defendants will divest all
of the germplasm from Monsanto’s MAB
program, as listed in Schedule E of the
proposed Final Judgment. This program
was intended to enable breeders to use
sophisticated molecular technology to
aid in the selection of promising lines
to advance to the next breeding stage.
Monsanto anticipated that Stoneville
varieties developed through the MAB
program would reach the market by
2011, and that MAB would be the
primary development source for the
varieties that Stoneville would
commercialize throughout the next
decade.2
Cotton States Germplasm: Defendants
will divest to the acquirer a nonexclusive, royalty-free license to sell
and breed with varieties from
Monsanto’s recently established Cotton
States program that Stoneville currently
sells today. In addition, as Monsanto
2 Although the Advanced Exotic Yield Lines and
MAB Populations provide the acquirer with
promising germplasm for expanding Stoneville’s
market share, they provide a limited platform for
introducing non-Monsanto traits because many of
these lines are already introgressed with Monsanto
traits. The proposed Final Judgment addresses this
limitation by requiring Defendants to allow the
acquirer to breed out Monsanto traits from these
lines (creating ‘‘Null Lines’’). Further, Defendants
are also required to provide any information
necessary for the acquirer to obtain regulatory
approval for varieties developed from Null Lines.
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
typically uses germplasm in the Cotton
States program that is owned by other
entities (the ‘‘Cotton States Licensors’’),
Monsanto will relinquish to the acquirer
the rights it possesses to work with the
Cotton States Licensors to
commercialize varieties that result from
pre-existing crosses of Stoneville
germplasm and Cotton States Licensors
germplasm.3
Other Germplasm: Defendants will
divest all other germplasm in Defendant
Monsanto’s possession, except that
Monsanto may retain, with certain
limitations, certain categories of
germplasm used predominantly in its
trait development and licensing
business.
3. DPL Germplasm
DPL’s success is due in significant
part to its large collection of highquality cotton germplasm from which it
breeds high-yielding varieties. To
ensure that the acquirer will have the
scale and scope necessary in the
Southeast and MidSouth to be an
effective and competitive platform for
trait development, Defendants will
divest twenty DPL conventional
varieties.4
Eight of the twenty varieties are in the
pedigrees of many of DPL’s popular
current varieties in the MidSouth and
Southeast. In particular, four of these
varieties (AZ2099, DP491, Delta Pearl,
and DP565) are the recurrent
conventional parents for DPL
commercial traited varieties that today
account for approximately 55% of the
cottonseed sold in the Southeast (where
Stoneville presently holds only an 8%
share of sales). Delta Pearl is the parent
of the high-yielding DPL555, which is
by far the dominant cottonseed variety
in the Southeast.
The twelve other divested DPL
varieties constitute a significant portion
of DPL’s breeding pipeline for the
MidSouth and Southeast and represent
the varieties, and breeding stock for the
varieties, that DPL had chosen to bring
to market over the next decade. These
twelve varieties were bred at the DPL
breeding stations that focus on
3 The proposed Final Judgment, however, does
not require Monsanto to divest its Cotton States
program. Insisting upon divestiture of the program
would have required obtaining consent from all of
the Cotton States Licensors and could have resulted
in disruption to the licensors’ financially beneficial
current contractual and business relationships with
Monsanto. Rather, this divestiture provides
Stoneville the ability to continue working with the
germplasm that it had been developing prior to the
acquisition.
4 In 2006, DPL purchased rights to germplasm
owned by Syngenta. Under the proposed Final
Judgment, Defendants will divest these
conventional lines to the acquirer in addition to the
twenty lines discussed above.
PO 00000
Frm 00023
Fmt 4701
Sfmt 4703
33357
developing germplasm well suited for
the MidSouth and Southeast. Over the
past four years, each of these twelve
varieties has been ranked by DPL during
the regular course of business as falling
within DPL’s top category for
conventional lines based on the
variety’s performance characteristics,
such as yield, fiber quality, and disease
resistance. The superiority of these
twelve lines is underscored by the fact
that DPL selected them for introgression
with the traits that DPL was developing
with Syngenta, as well as for
introgression with Monsanto’s latest
insect-resistant and herbicide-tolerant
traits.
The proposed Final Judgment permits
Defendants to retain a license to
continue using these twenty lines to
breed new varieties and to sell
exclusively varieties that contain only
Monsanto’s traits. This exception to
total divestiture (i.e., permitting
Defendants to continue selling varieties
currently in the market and continue
breeding with the divested varieties) is
necessary to preserve DPL’s current
competitiveness, prevent disruption to
its breeding program, and provide DPL
the ability to compete effectively in the
future. The acquirer of the Enhanced
Stoneville Assets will have use of these
varieties for its breeding program and
will have rights to commercialize
varieties (including in the MidSouth
and Southeast) that contain traits being
developed by other trait providers,
either alone or in combination with
Monsanto’s traits.5 With these rights,
the acquirer will be in a position to
provide trait developers with a
competitive alternative to DPL going
forward.
The proposed Final Judgment allows
Defendants to continue, for a limited
period of time, to sell conventional
versions of some of the divested DPL
varieties currently being sold by DPL in
and outside of the United States,
providing for a continuity of supply of
conventional cottonseed.
4. Defendant Monsanto Must Divest DPL
if Enhanced Stoneville Assets Are Not
Divested in a Timely Manner
In merger cases where the United
States seeks a divestiture remedy, it
requires completion of the divestitures
5 The proposed Final Judgment limits the acquirer
in one respect with regard to non-Monsanto traits.
For seven years, Monsanto may prevent it from
‘‘triple-stacking’’ in the twenty varieties a Monsanto
glyphosate-tolerant trait, a Monsanto insectresistant trait, and any non-glyphosate herbicidetolerant trait available at the time the Complaint
was filed. Nothing in the decree, however, prohibits
Monsanto or the acquirer from commercializing
such a triple-stacked cottonseed if licenses could be
obtained from all affected rights-holders.
E:\FR\FM\15JNN2.SGM
15JNN2
33358
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
rwilkins on PROD1PC63 with NOTICES2
within the shortest time period
reasonable under the circumstances. In
this case, the proposed Final Judgment
provides that Defendants must complete
the divestiture within ninety (90)
calendar days after the filing of the
Complaint. Defendants must use their
best efforts to divest the Enhanced
Stoneville Assets as expeditiously as
possible. The United States, in its sole
discretion, may grant one or more
extensions of time, not to exceed sixty
(60) calendar days in total.
In the event that Defendants do not
accomplish the divestiture of the
Enhanced Stoneville Assets within the
time period permitted in the proposed
Final Judgment, the proposed Final
Judgment provides that Defendant
Monsanto shall divest DPL within sixty
(60) days. Requiring divestiture of the
acquired company would be necessary
to ensure the full restoration of
competition as quickly as possible
should Defendants not be able to divest
the Enhanced Stoneville Assets in an
acceptable manner.
If the Defendant Monsanto has not
divested DPL within the time period
permitted by the proposed Final
Judgment, then a trustee shall be
appointed by the Court upon
application of the United States. The
proposed Final Judgment provides that
Monsanto will pay all costs and
expenses of the trustee. The trustee’s
commission will be structured so as to
provide an incentive for the trustee
based on the price obtained and the
speed with which the divestiture is
accomplished. After the trustee’s
appointment becomes effective, the
trustee will file monthly reports with
the Court and the United States setting
forth the trustee’s efforts to accomplish
the divestiture of DPL. At the end of
ninety (90) calendar days, if the
divestiture has not been accomplished,
the trustee and the United States will
make recommendations to the Court,
which shall enter such orders as
appropriate, in order to carry out the
purpose of the trust, including
extending the trust or the term of the
trustee’s appointment.
B. The Syngenta/VipCot Divestiture
The proposed Final Judgment requires
Defendants to divest to Syngenta the
VipCot Assets listed in Schedule C of
the proposed Final Judgment. This
divestiture seeks to minimize any delay
the acquisition could cause in the
commercialization of cottonseed
containing VipCot, Syngenta’s insectresistant trait technology that would
compete against Monsanto’s Bollgard
family of traits. The VipCot assets
include forty-three lines of DPL
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
germplasm into which DPL has
incorporated VipCot, along with
performance data and other
information.6 These lines are based on
the most promising germplasm that DPL
has in its development pipeline for
geographies across the Cotton Belt,
including the MidSouth and Southeast.
They are at various stages of
development, with DPL anticipating
commercializing varieties from five of
these lines as early as 2009, three in
2010 or 2011, and the remainder in 2011
and beyond.
The lines will be transferred to
Syngenta along with certain rights to
allow Syngenta, by itself or working
with others, to bring these varieties to
market. Syngenta will have exclusive
rights to commercialize varieties
developed from these lines so long as
the variety has at least one of the
Syngenta trait events listed in Schedule
C of the proposed Final Judgment,
which includes the events that form
VipCot. Syngenta will also have
exclusive rights to breed with the
Syngenta-traited versions of these lines.
To facilitate breeding, Monsanto will
provide Syngenta the ‘‘recurrent parent’’
conventional germplasm for each of the
divested lines until December 21, 2014,
which will allow Syngenta to complete
development of these lines and add
other traits.
The proposed Final Judgment also
requires Monsanto to offer Syngenta a
license to Roundup Ready Flex so that
Syngenta can commercialize these
VipCot lines stacked with Roundup
Ready Flex. Such a license will permit
Syngenta to advance these lines by
introgressing Roundup Ready Flex into
them. It will also permit Syngenta to
sell, either independently or in
conjunction with an established
cottonseed company with a Roundup
Ready Flex license, varieties stacked
with VipCot and Flex.
The VipCot divestiture to Syngenta
will therefore allow Syngenta to
commercialize VipCot on the same
schedule as DPL’s anticipated
commercialization and with the same
range of options regarding stacking
herbicide tolerance or other traits.
Defendants must use their best efforts to
divest the VipCot Assets as
expeditiously as possible and shall not
take any action that would harm the
VipCot Assets or in any way impede
their divestiture.
6 One of the forty-three lines is a line that DPL
purchased from Syngenta in 2006 into which DPL
introduced VipCot.
PO 00000
Frm 00024
Fmt 4701
Sfmt 4703
Changes in Third Party Licenses
The proposed Final Judgment requires
Monsanto to modify its third-party
cottonseed trait and Cotton States Lines
licenses no later than ten (10) days after
the date of sale of the Enhanced
Stoneville Assets, subject to the
approval of the United States in its sole
discretion. Monsanto will modify its
third-party cottonseed trait licenses to
remove restrictions on the ability of
licensees to develop, market, or sell
cottonseed containing traits of
companies other than Monsanto, or to
combine the licensed Monsanto traits in
cottonseed with the traits of other
companies. Monsanto will also modify
the Cotton States Lines licenses to
eliminate any provision that allows
Monsanto to terminate the license if the
licensee sells cottonseed containing
other traits.
These changes will give these
competing cottonseed companies the
ability to partner with trait developers
other than Monsanto without any
financial penalty and to offer traits
desired by farmers. Trait developers will
thereby have access to close to half of
the current U.S. cottonseed market,
without having to deal with the
combined Monsanto/DPL. These
changes will ensure that Monsanto
cannot prevent trait developers from
bringing competing, non-Monsanto
traits to the market.
D. Notice Provisions
The proposed Final Judgment
provides that Defendant Monsanto shall
provide notice to the United States prior
to acquiring any company that develops
and sells cottonseed in the United States
or has developed, or has under
development, traits for
commercialization in cottonseed in the
United States, unless the transaction is
otherwise subject to Hart-Scott-Rodino
reporting requirements. This provision
will allow the United States to assess
whether any such transaction would be
likely to substantially lessen
competition.
IV. Remedies Available to Potential
Private Litigants
Section 4 of the Clayton Act (15
U.S.C. 15) provides that any person who
has been injured as a result of conduct
prohibited by the antitrust laws may
bring suit in federal court to recover
three times the damages the person has
suffered, as well as costs and reasonable
attorneys’ fees. Entry of the proposed
Final Judgment will neither impair nor
assist the bringing of any private
antitrust damage action. Under the
provisions of Section 5(a) of the Clayton
E:\FR\FM\15JNN2.SGM
15JNN2
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
Act (15 U.S.C. 16(a)), the proposed Final
Judgment has no prima facie effect in
any subsequent private lawsuit that may
be brought against Defendants.
rwilkins on PROD1PC63 with NOTICES2
V. Procedures Available for
Modification of the Proposed Final
Judgment
The United States and Defendants
have stipulated that the proposed Final
Judgment may be entered by the Court
after compliance with the provisions of
the APPA, provided that the United
States has not withdrawn its consent.
The APPA conditions entry upon the
Court’s determination that the proposed
Final Judgment is in the public interest.
The APPA provides a period of at
least sixty (60) days preceding the
effective date of the proposed Final
Judgment within which any person may
submit to the United States written
comments regarding the proposed Final
Judgment. Any person who wishes to
comment should do so within sixty (60)
days of the date of publication of this
Competitive Impact Statement in the
Federal Register, or the last date of
publication in a newspaper of the
summary of this Competitive Impact
Statement, whichever is later. All
comments received during this period
will be considered by the United States
Department of Justice, which remains
free to withdraw its consent to the
proposed Final Judgment at any time
prior to the Court’s entry of judgment.
The comments and the response of the
United States will be filed with the
Court and published in the Federal
Register.
Written comments should be
submitted to: Donna N. Kooperstein,
Chief, Transportation, Energy &
Agriculture Section, Antitrust Division,
United States Department of Justice, 325
Seventh Street, NW., Suite 500,
Washington, DC 20530.
The proposed Final Judgment
provides that the Court retains
jurisdiction over this action, and the
parties may apply to the Court for any
order necessary or appropriate for the
modification, interpretation, or
enforcement of the Final Judgment.
VI. Alternatives to the Proposed Final
Judgment
The United States considered, as an
alternative to the proposed Final
Judgment, a full trial on the merits
against Defendants. The United States
could have continued the litigation and
sought preliminary and permanent
injunctions against Monsanto’s
acquisition of DPL. The United States is
satisfied, however, that the divestiture
of assets and other relief described in
the proposed Final Judgment will
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
preserve competition in the market for
the development, production, and sale
of traited cottonseed. Thus, the
proposed Final Judgment would achieve
all or substantially all of the relief the
United States would have obtained
through litigation, but avoids the time,
expense, and uncertainty of a full trial
on the merits of the Complaint.
VII. Standard of Review Under the
APPA for the Proposed Final Judgment
The APPA requires that proposed
consent judgments in antitrust cases
brought by the United States be subject
to a sixty-day comment period, after
which the Court shall determine
whether entry of the proposed Final
Judgment ‘‘is in the public interest.’’ 15
U.S.C. 16(e)(1). In making that
determination, the court, in accordance
with amendments to the APPA in 2004,
is required to consider:
(A) The competitive impact of such
judgment, including termination of alleged
violations, provisions for enforcement and
modification, duration of relief sought,
anticipated effects of alternative remedies
actually considered, whether its terms are
ambiguous, and any other competitive
considerations bearing upon the adequacy of
such judgment that the court deems
necessary to a determination of whether the
consent judgment is in the public interest;
and
(B) The impact of entry of such judgment
upon competition in the relevant market or
markets, upon the public generally and
individuals alleging specific injury from the
violations set forth in the complaint
including consideration of the public benefit,
if any, to be derived from a determination of
the issues at trial.
15 U.S.C. 16(e)(1)(A) & (B); see generally
United States v. SBC Commc’ns, Inc.,
Nos. 05–2102 and 05–2103,2007 WL
1020746, at *9–16 (D.D.C. Mar. 29,
2007) (assessing public interest standard
under APPA and effect of 2004
amendments).7 Courts in this circuit
have held—both before and after the
2004 amendments—that the United
States is entitled to deference in crafting
its antitrust settlements, especially with
respect to the scope of its complaint and
the adequacy of its remedy, which are
the ‘‘two most significant legal
questions’’ relating to a public interest
determination. United States v.
7 Compare 15 U.S.C. 16(e) (2004), with 15 U.S.C.
16(e)(1) (2006) (substituting ‘‘shall’’ for ‘‘may’’ in
directing relevant factors for court to consider and
amending list of factors to focus on competitive
considerations and to address potentially
ambiguous judgment terms). The 2004 amendments
do not affect the substantial precedent in this and
other circuits analyzing the scope and standard of
review for APPA proceedings. See SBC Commc’ns,
2007 WL 1020746, at *9 (‘‘[A] close reading of the
law demonstrates that the 2004 amendments
effected minimal changes. * * * ’’).
PO 00000
Frm 00025
Fmt 4701
Sfmt 4703
33359
Microsoft Corp., 56 F.3d 1448, 1458–62
(D.C. Cir. 1995); SBC Commc’ns, 2007
WL 1020746, at *12–*16.8
With respect to the adequacy of the
relief secured by the decree, a court may
not ‘‘engage in an unrestricted
evaluation of what relief would best
serve the public.’’ United States v. BNS,
Inc., 858 F.2d 456, 462 (9th Cir. 1988)
(citing United States v. Bechtel Corp.,
648 F.2d 660, 666 (9th Cir. 1981)); see
also Microsoft, 56 F.3d at 1460–62.
Courts have held that:
[t]he balancing of competing social and
political interests affected by a proposed
antitrust consent decree must be left, in the
first instance, to the discretion of the
Attorney General. The court’s role in
protecting the public interest is one of
insuring that the government has not
breached its duty to the public in consenting
to the decree. The court is required to
determine not whether a particular decree is
the one that will best serve society, but
whether the settlement is ‘‘within the reaches
of the public interest.’’ More elaborate
requirements might undermine the
effectiveness of antitrust enforcement by
consent decree.
Bechtel, 648 F.2d at 666 (emphasis
added) (citations omitted).9 In making
its public interest determination, a
district court must accord due respect to
the United States’ prediction as to the
effect of proposed remedies, its
perception of the market structure, and
its views of the nature of the case. SBC
Commc’ns, 2007 WL 1020746, at *16
(United States entitled to ‘‘deference’’ as
to ‘‘predictions about the efficacy of its
remedies’’); United States v. ArcherDaniels-Midland Co., 272 F. Supp. 2d 1,
6 (D.D.C. 2003).
Court approval of a final judgment
requires a standard more flexible and
less strict than the standard required for
a finding of liability. ‘‘[A] proposed
decree must be approved even if it falls
short of the remedy the court would
impose on its own, as long as it falls
8 The Microsoft court explained that a court
making a public interest determination under the
APPA should consider, among other things, the
relationship between the remedy secured and the
specific allegations set forth in the government’s
complaint, whether the decree is sufficiently clear,
whether enforcement mechanisms are sufficient,
and whether the decree may positively harm third
parties. Microsoft, 56 F.3d at 1458–62.
9 Cf BNS, 858 F.2d at 464 (holding that the court’s
‘‘ultimate authority under the [APPA] is limited to
approving or disapproving the consent decree’’);
United States v. Gillette Co., 406 F. Supp. 713, 716
(D. Mass. 1975) (noting that, in this way, the court
is constrained to ‘‘look at the overall picture not
hypercritically, nor with a microscope, but with an
artist’s reducing glass’’), aff’d sub nom. Maryland v.
United States, 460 U.S. 1001 (1983). See generally
Microsoft, 56 F.3d at 1461 (discussing whether ‘‘the
remedies [obtained in the decree are] so
inconsonant with the allegations charged as to fall
outside of the ‘reaches of the public interest’ ’’).
E:\FR\FM\15JNN2.SGM
15JNN2
33360
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
rwilkins on PROD1PC63 with NOTICES2
within the range of acceptability or is
‘within the reaches of public interest.’ ’’
United States v. AT&T Co., 552 F. Supp.
131, 151 (D.D.C. 1982) (citations
omitted) (quoting Gillette, 406 F. Supp.
at 716); see also United States v. Alcan
Aluminum Ltd., 605 F. Supp. 619, 622
(W.D. Ky. 1985) (approving the consent
decree even though the court would
have imposed a greater remedy). To
meet this standard, the United States
‘‘need only provide a factual basis for
concluding that the settlements are
reasonably adequate remedies for the
alleged harms.’’ SBC Commc’ns, 2007
WL 1020746, at *16.
Moreover, the Court’s role under the
APPA is limited to reviewing the
remedy in relationship to the violations
that the United States has alleged in its
Complaint, and does not authorize the
Court to ‘‘construct [its] own
hypothetical case and then evaluate the
decree against that case.’’ Microsoft, 56
F.3d at 1459. Because the ‘‘court’s
authority to review the decree depends
entirely on the government’s exercising
its prosecutorial discretion by bringing
a case in the first place,’’ it follows that
‘‘the court is only authorized to review
the decree itself,’’ and not to ‘‘effectively
redraft the complaint’’ to inquire into
other matters that the United States did
not pursue. Id. at 1459–60. As this Court
recently confirmed in SBC
Communications, courts ‘‘cannot look
beyond the complaint in making the
public interest determination unless the
complaint is drafted so narrowly as to
make a mockery of judicial power.’’ SBC
Commc’ns, 2007 WL 1020746, at *14.
In its 2004 amendments to the
Tunney Act, Congress made clear its
VerDate Aug<31>2005
20:04 Jun 14, 2007
Jkt 211001
intent to preserve the practical benefits
of utilizing consent decrees in antitrust
enforcement, adding the unambiguous
instruction ‘‘[n]othing in this section
shall be construed to require the court
to conduct an evidentiary hearing or to
require the court to permit anyone to
intervene.’’ 15 U.S.C. 16(e)(2). This
language codified the intent of the
original 1974 statute, expressed by
Senator Tunney in the legislative
history: ‘‘[t]he court is nowhere
compelled to go to trial or to engage in
extended proceedings which might have
the effect of vitiating the benefits of
prompt and less costly settlement
through the consent decree process.’’
119 Cong. Rec. 24,598 (1973) (statement
of Senator Tunney). Rather, the
procedure for the public interest
determination is left to the discretion of
the court, with the recognition that the
court’s ‘‘scope of review remains
sharply proscribed by precedent and the
nature of Tunney Act proceedings.’’
SBC Commc’ns, 2007 WL 1020746, at
*9.10
Dated: May 31, 2007.
Respectfully submitted,
For Plaintiff
Jill A. Ptacek (WA Bar #18756),
Trial Attorney, U.S. Department of Justice,
Antitrust Division, Transportation, Energy &
Agriculture Section, 325 7th Street, NW.,
Suite 500, Washington, DC 20004,
Telephone: (202) 307–6607, Facsimile: (202)
307–2784.
[FR Doc. 07–2897 Filed 6–14–07; 8:45 am]
BILLING CODE 4410–11–M
VIII. Determinative Documents
There are no determinative materials
or documents within the meaning of the
APPA that were considered by the
United States in formulating the
proposed Final Judgment.
10 United States v. Mid-Am. Dairymen, Inc.,
1977–1 Trade Cas. (CCH) ¶ 61,508, at 71,980 (W.D.
Mo. 1977) (‘‘[T]he Court, in making its public
interest finding, should * * * carefully consider
the explanations of the government in the
competitive impact statement and its responses to
comments in order to determine whether those
explanations are reasonable under the
circumstances.’’).
PO 00000
Frm 00026
Fmt 4701
Sfmt 4703
E:\FR\FM\15JNN2.SGM
15JNN2
Agencies
[Federal Register Volume 72, Number 115 (Friday, June 15, 2007)]
[Notices]
[Pages 33336-33360]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-2897]
[[Page 33335]]
-----------------------------------------------------------------------
Part III
Department of Justice
-----------------------------------------------------------------------
Antitrust Division
-----------------------------------------------------------------------
United States v. Monsanto Co.; Proposed Final Judgement and Competitive
Impact Statement; Notice
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 /
Notices
[[Page 33336]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
United States v. Monsanto Co.; Proposed Final Judgment and
Competitive Impact Statement
Notice is hereby given pursuant to the Antitrust Procedures and
Penalties Act, 15 U.S.C. 16(b)-(h), that a Complaint, proposed Final
Judgment, Hold Separate and Preservation of Assets Stipulation and
Order, and Competitive Impact Statement have been filed with the United
States District Court for the District of Columbia in United States v.
Monsanto Co., Civ. Action No. 1:07CV00992. On May 31, 2007, the United
States filed a Complaint alleging that the proposed acquisition by
Monsanto Company (``Monsanto'') of Delta and Pine Land Company
(``DPL'') would violate Section 7 of the Clayton Act, 15 U.S.C. 18. The
Complaint alleges that the acquisition would substantially reduce
competition for the development, breeding, and sale of traited
cottonseed in the MidSouth (Mississippi, Arkansas, Louisiana, Missouri,
and Tennessee) and Southeast (Alabama, Georgia, Florida, South
Carolina, North Carolina, and Virginia) United States. Specifically,
the Complaint alleges that Monsanto's acquisition of Delta and Pine
Land would enhance Monsanto's ability and incentive to raise traited
cottonseed prices and eliminate Delta and Pine Land as a partner
independent of Monsanto for competing trait developers. The proposed
Final Judgment, lodged at the same time as the Complaint, requires the
parties to divest (1) Monsanto's Stoneville Pedigreed Seed Company; (2)
other Monsanto cotton breeding assets; (3) specified lines of Delta and
Pine Land cottonseed to the acquirer of the Stoneville assets; (4) and
specified lines of Delta and Pine Land cottonseed containing the VipCot
transgenic trait to Syngenta AG. It also requires Monsanto to modify
certain licenses. A Competitive Impact Statement filed by the United
States describes the Complaint, the proposed Final Judgment, and the
remedies available to private litigants who may have been injured by
the alleged violation.
Copies of the Complaint, proposed Final Judgment, Hold Separate and
Preservation of Assets Stipulation and Order, and Competitive Impact
Statement are available for inspection at the Department of Justice,
Antitrust Division, 325 7th Street, NW., Suite 215, Washington, DC
20530 (202-514-2481), on the Internet at https://www.usdoj.gov/atr, and
at the Office of the Clerk of the United States District Court for the
District of Columbia. Copies of these materials may be obtained from
the Antitrust Division upon request and payment of the copying fee.
Public comment is invited within sixty (60) days of the date of
this notice. Such comments, and responses thereto, will be published in
the Federal Register and filed with the Court. Comments should be
directed to Donna N. Kooperstein, Chief, Transportation, Energy &
Agriculture Section, Antitrust Division, Department of Justice, 325 7th
Street, NW., Suite 500, Washington, DC 20530 (202-307-6349).
J. Robert Kramer II,
Director of Operations, Antitrust Division.
United States District Court for the District of Columbia
United States of America, Department of Justice, Antitrust
Division, 325 7th Street, NW., Suite 500, Washington, DC 20530,
Plaintiff, v. Monsanto Company, 800 North Lindbergh Boulevard, St.
Louis, MO 63167, and Delta and Pine Land Company, 1 Cotton Row, Scott,
MS 38772, Defendants
Civil Case No.:
Case: 1:07-cv-00992.
Assigned To: Urbina, Ricardo M.
Assign. Date: 5/31/2007.
Description: Antitrust.
Complaint
The United States of America, acting under the direction of the
Attorney General of the United States, brings this civil action to
enjoin the merger of defendants Monsanto Company (``Monsanto'') and
Delta and Pine Land Company (``DPL'') and allege as follows:
1. In 2006, cottonseed was planted on more than 15 million acres in
the United States and generated more than $5 billion in annual revenues
for United States farmers. Cotton is grown across the Southern United
States from Virginia, the Carolinas, Georgia, and Florida on the East
Coast to California on the West Coast.
2. Farmers grow substantially all of this important crop from
cottonseed that has been enhanced through the introduction of
biotechnology traits (``traited cottonseed''). Traited cottonseed
results from combining cottonseed stock that has attractive growing
characteristics (such as producing a high yield of cotton per acre)
with performance traits foreign to cotton that are inserted through
genetic engineering.
3. Monsanto is the largest producer and supplier of biotechnology
traits sold in cottonseed in the United States, with over 96% of United
States traited cottonseed containing Monsanto traits. Monsanto is also
one of the largest sellers of traited cottonseed in the United States,
primarily through its Stoneville Pedigreed Seed Company
(``Stoneville'').
4. DPL is the largest producer of cottonseed in the United States.
DPL is the leading seller in the MidSouth (Mississippi, Arkansas,
Louisiana, Missouri, and Tennessee), where DPL sells 79% of all traited
cottonseed, and the Southeast (Alabama, Georgia, Florida, South
Carolina, North Carolina, and Virginia), where DPL sells 87% of all
traited cottonseed.
5. In the 1980s, Monsanto partnered with DPL to introduce
cottonseed containing Monsanto traits. DPL's experienced and
knowledgeable cotton breeders and large collection of high-quality
germplasm (the genetic material of a cottonseed that gives the plant
its characteristics) provided Monsanto with an unparalleled avenue
through which to commercialize and market its traits. The combination
of Monsanto traits and DPL cottonseed has been highly successful,
particularly in the MidSouth and Southeast, due to the performance of
DPL's cottonseed and the value of Monsanto's biotechnology traits in
those regions.
6. Monsanto's position as the dominant supplier of traits used in
cottonseed was jeopardized in the early 2000s when DPL began to partner
with other biotechnology companies. Through these partnerships, DPL's
germplasm library and breeding capabilities were available to
alternative trait developers, allowing them to work toward introducing
new traits in DPL cottonseed that would compete with Monsanto's traits.
DPL publicly stated its intent to replace Monsanto traits in its
products and planned to launch products with non-Monsanto traits as
early as the 2009 growing season, with additional products to follow.
7. Spurred by this competitive threat and recognizing the potential
for a successful pairing of DPL's cottonseed with competing traits,
Monsanto purchased Stoneville to position Monsanto to compete
vigorously with DPL. Monsanto aggressively worked to develop
Stoneville's germplasm and its traited cottonseed sales and also
continued its efforts to develop germplasm and expand traited
cottonseed sales through its Cotton States business unit.
8. The proposed merger will consolidate Monsanto's and DPL's
traited cottonseed sales, eliminating competition between these firms
in the sale of cottonseed. DPL and Monsanto
[[Page 33337]]
together would control over 95% of sales in the important MidSouth and
Southeast regions, where harvested cotton garners higher prices per
bale, and where cottonseed traits are most valued by farmers. The
proposed merger will also eliminate DPL as a partner independent of
Monsanto for competing trait developers, substantially delaying or
preventing the development and introduction of cottonseed containing
non-Monsanto traits. Accordingly, Monsanto's merger with DPL would
substantially lessen competition in violation of Section 7 of the
Clayton Act, 15 U.S.C. 18.
Jurisdiction and Venue
9. This action is filed by the United States under Section 15 of
the Clayton Act, as amended, 15 U.S.C. 25, to prevent and restrain
Defendants from violating Section 7 of the Clayton Act, 15 U.S.C. 18.
10. Monsanto and DPL are engaged in interstate commerce and in
activities substantially affecting interstate commerce. The Court has
jurisdiction over this action and the parties pursuant to Sections 15
and 16 of the Clayton Act, 15 U.S.C. 25, 26; and 28 U.S.C. 1331, 1337.
11. The Defendants have consented to personal jurisdiction and
venue in this judicial district.
II. The Defendants
12. Defendant Monsanto is a Delaware corporation, with its
headquarters located in St. Louis, Missouri. Monsanto is a leading
global provider of agricultural products for farmers, including seeds
for cotton, soybeans, and corn; traits that help farmers control
insects and weeds; and crop protection chemicals such as the herbicide
Roundup, a branded version of the chemical glyphosate. Monsanto had
total company revenues of more than $7.3 billion in 2006.
13. Defendant DPL is a Delaware corporation, with its headquarters
located in Scott, Mississippi. DPL is the largest cottonseed producer
in the world. DPL's sales in the United States in 2006 exceeded $400
million.
III. Trade and Commerce
A. Affected Commerce
Cottonseed Varieties
14. Cottonseed varieties differ in their performance, including the
yield, the strength and the length of the cotton fibers, and the
adaptability of the cottonseed to specific weather conditions and soil
types. Varieties that perform best in certain regions of the country,
such as the drier areas of the Southwest (including West Texas, Kansas,
and Oklahoma) do not typically perform well in other regions, such as
the MidSouth and the Southeast. Farmers select cottonseed varieties
that have the best performance characteristics for the area in which
the cottonseed will be planted, with the primary focus on yield.
15. To be competitive, cottonseed companies must continually work
on developing new and improved cottonseed varieties through their
breeding programs. Cotton breeding is a costly and time-consuming
process in which the cottonseed company selects lines to breed together
(or ``cross''), plants the cottonseed produced from that initial cross,
and then selects the best plants for further crossing to create a
variety with the desired characteristics. In most cases, it takes eight
to ten years from the initial cross until a new cottonseed variety is
ready for market.
16. The success of a cottonseed company's breeding program is
dependent on many factors, the most important of which is the quantity
and quality of available breeding materials, i.e. germplasm. A company
with a large collection of high quality, or elite, germplasm has a
competitive advantage because the company has the ability to identify
the best genetic material and use it in a wide variety of possible
crossing combinations, resulting in a greater likelihood of developing
a successful variety.
17. DPL has the largest cotton germplasm collection, with by far
the greatest track record of success in the important MidSouth and
Southeast regions, and an extensive breeding program for cottonseed. It
has eight research or breeding facilities in the United States and five
located elsewhere in the world. It has more breeding capabilities than
any competitor and over ninety years of germplasm development.
Traits for Cottonseed
18. Historically, farmers grew cotton from conventional cottonseed
that contained naturally occurring characteristics. Cotton farming with
conventional cottonseed involved labor intensive and costly herbicide
and insecticide spraying programs that required multiple applications
at very specific times in the growing season. Failure to spray or to
correctly time the applications could result in substantial crop
damage.
19. In the 1980s, Monsanto developed a trait that could be inserted
into cotton plants to make plants resistant to certain insects. It also
developed an herbicide-tolerant trait that would make cotton plants
grown from cottonseed with the trait resistant to certain herbicides
sprayed to kill weeds, allowing farmers to spray herbicides less
precisely without killing the young plants.
20. To gain acceptance by farmers, the traits had to be delivered
in cottonseed lines that performed well in the growing area where the
farmer was located. In 1988, Monsanto approached DPL to develop and
commercialize cottonseed with the Monsanto insect-resistant and
herbicide-tolerant traits. DPL was then, and still is, the market
leader in cottonseed, with what was considered the best germplasm and
the most sought-after varieties.
21. The companies proceeded with the development and
commercialization process, which involved inserting the Monsanto trait
into DPL germplasm, evaluating plant lines grown from that germplasm,
and breeding promising candidate plants to produce varieties with
desired characteristics. In 1996, DPL began to sell the first
cottonseed with Monsanto's initial insect-resistant trait (marketed
under the name ``Bollgard''), and, the following year, it introduced a
variety with Monsanto's initial herbicide-tolerant trait (marketed
under the name ``Roundup Ready'').
22. Farmers, particularly those in the MidSouth and Southeast,
quickly adopted traited cottonseed because its use significantly
lowered overall farming costs, increased yields, and reduced the risk
of crop loss. Today, almost all cottonseed varieties planted in the
United States are traited, and, in 2006, over 96% of the traited
cottonseed sold in the United States contained traits developed by
Monsanto.
23. When farmers acquire traited cottonseed, they pay a price per
bag to the seed distributor, who pays the seed manufacturer for the
seed, and a separate license fee (commonly referred to as the
``technology fee'') to the developer of the trait. Typically, the trait
developer shares a portion of the technology fee with the seed
manufacturer. The technology fee can constitute as much as 80% of
farmers' total costs for a bag of traited cottonseed.
DPL's Trait Development With Monsanto's Competitors
24. Following Monsanto's and DPL's successful introduction
oftraited cottonseed, they agreed in 1998 that Monsanto would acquire
DPL. The Antitrust Division of the United States Department of Justice
investigated the proposed transaction. In late 1999, while the
transaction was still under review, Monsanto decided to abandon
[[Page 33338]]
the transaction. DPL thus remained an independent company.
25. Despite ensuing litigation from the companies' failed attempt
to merge, DPL continued to develop and market cottonseed varieties with
Monsanto's traits. DPL also commenced a strategy to replace (or
``trade-out'') the Monsanto traits in DPL cottonseed with traits of
other companies. DPL believed that this strategy would be profitable
for DPL because competing trait developers would offer DPL a higher
percentage of the technology fee for traits than would Monsanto. In
DPL's suit against Monsanto for breach of the merger agreement, DPL
alleged significant financial losses resulting from the delay that the
failed merger caused to DPL's efforts to develop traits with companies
other than Monsanto.
26. Pursuant to the trade-out strategy, DPL has worked with several
other biotechnology companies, including Dow AgroSciences, DuPont,
Syngenta Crop Protection AG and Bayer CropScience, to develop and
commercialize cottonseed containing the traits developed by these
companies that would compete with cottonseed containing Monsanto's
traits. DPL is an attractive partner that is well suited to quickly
introduce new trait technologies due to the strength and breadth of its
germplasm base and breeding programs as well as its technical service
capabilities, know-how, brand recognition and market position.
27. DPL's trait license with Monsanto also makes DPL an attractive
partner for competing trait developers. Most farmers in the United
States buy cottonseed containing traits that provide both herbicide
tolerance and insect resistance. In the MidSouth and Southeast United
States, the vast majority of farmers use both traits. DPL's trait
licenses with Monsanto allow DPL to offer competing trait developers
the ability to combine or ``stack'' their traits in DPL cottonseed
along with Monsanto traits. This stacking right would allow, for
example, the developer of an insect-resistant trait to bring that trait
to market in cottonseed that also contains a Monsanto herbicide-
tolerant trait (i.e., Roundup Ready or the more-recent version, Roundup
Ready Flex). Monsanto's trait licenses with most other cottonseed
companies, by contrast, severely restrict the ability of these
companies to work with other trait developers, with some of these
licenses prohibiting the stacking of cottonseed containing Monsanto
traits with another company's traits and others subjecting the
licensees to severe penalties if they stack non-Monsanto traits with
Monsanto traits.
28. Even with the advantages that partnering with DPL offers
Monsanto's competing trait developers, the process to develop, breed
and commercialize cotton varieties with traits typically takes eight to
twelve years and costs over $40 million. The process often requires
thousands of attempts before developing a traited cottonseed that then
can be used to breed commercial varieties. In addition, extensive
regulatory approvals, both in the United States and abroad, are
required.
29. DPL's trait-development work with Monsanto's competitors has
recently begun to show results. DPL's developmental work with Syngenta
resulted in a 2004 agreement to commercialize cottonseed with
Syngenta's VipCot insect-resistant traits. DPL expects to begin
marketing such cottonseed as early as 2009. The DPL/Syngenta agreement
provides that DPL will receive 70% of the net trait technology fees
earned through sales of this product, compared with the 30% that DPL
earns pursuant to its Monsanto agreement.
Monsanto's Competitive Reaction to DPL's ``Trade-Out'' Plan
30. Monsanto recognized that its and DPL's ``paths will continue to
diverge'' as DPL continues its strategy to replace Monsanto traits in
DPL cottonseed with traits developed by Monsanto's competitors. Driven
by the competitive threat posed by DPL's work with these other
companies, Monsanto set about building its own cottonseed business.
31. In 2002, Monsanto began Cotton States, through which Monsanto
obtains licenses on germplasm developed by private breeders and
universities, breeds its traits into the germplasm, and out-licenses
the resulting traited varieties to sellers of cottonseed for sale under
their private labels.
32. In 2005, Monsanto repurchased Stoneville, the second-largest
traited cottonseed company in the MidSouth and Southeast United States.
Monsanto had previously owned Stoneville but sold it in 1999 before
abandoning its attempt to acquire DPL. Upon reacquiring Stoneville,
Monsanto immediately invested capital to improve Stoneville's
competitive position.
33. Monsanto aggressively worked to strengthen its cottonseed
business by, among other things, focusing on advanced breeding
techniques and germplasm development and investing in breeding
facilities. Monsanto predicted internally that these investments would
enable Monsanto to increase its share of the cottonseed business at the
expense of DPL and other companies.
B. Relevant Markets
34. Across regions such as the MidSouth and Southeast, growing
conditions for cotton differ due to weather conditions, soil type, and
varied demands for weed and insect control. Fanners demand cottonseed
varieties that produce high yield for their particular growing
conditions. Monsanto and DPL recognize this demand and market
cottonseed varieties by region.
35. In many regions of the country, including the MidSouth and
Southeast, farmers demand that cottonseed have traits to provide insect
resistance and herbicide tolerance. Monsanto prices traits by region.
36. Cotton fanners consider cotton the most valuable crop for their
land, and the cost of the traited cottonseed amounts to only a fraction
of the total cost of growing cotton. If there were a small but
significant increase in price of traited cottonseed within regions such
as the MidSouth and Southeast, it is not likely that farmers would
switch to other crops or switch purchases to conventional (non-traited)
cottonseed or cottonseed varieties not well suited for their regions in
sufficient volumes to make the price increase unprofitable. The
development, commercialization, and sale of traited cottonseed
constitutes a line of commerce or product market, and the MidSouth and
Southeast United States are sections of the country or geographic
markets, within the meaning of Section 7 of the Clayton Act.
IV. Anticompetitive Effects
A. Concentration
37. DPL is the largest firm in the traited cottonseed market in the
United States. It is even more dominant in the MidSouth United States
market, with 79% of the traited cottonseed sales, and the Southeast
United States market, with over 87% of the traited cottonseed sales.
38. Monsanto is the second-largest traited cottonseed company in
the MidSouth and Southeast United States markets, with 17% of sales in
the MidSouth United States market and 8% of sales in the Southeast
United States market.
39. After the merger, Monsanto would account for more than 95% of
sales of traited cottonseed in the MidSouth United States market and
95% of sales in the Southeast United States market.
40. Using a measure of market concentration called the Herfindahl-
[[Page 33339]]
Hirschman Index (``HHI''), explained in Appendix A, Monsanto's merger
with DPL would result in a post-merger HHI of 9110 in the MidSouth
United States market, with an increase of 331O, and a post-merger HHI
of 9184 in the Southeast United States, with an increase of 1489.
B. Effect of Transaction
41. The merger will eliminate competition between DPL and Monsanto
for the development, breeding, and sale of traited cottonseed. As a
result, farmers likely will have fewer choices of, and face higher
prices for, traited cottonseed.
42. The merger will also eliminate DPL as a partner independent of
Monsanto for developers of traits that would compete against Monsanto.
DPL's current efforts to develop and commercialize cottonseed with
Syngenta's VipCot insect-resistant technology, which would be
competitive with Monsanto's Bollgard and more-recent Bongard II traits,
will be substantially delayed or prevented. Further, the merger will
likely delay if not deter efforts to develop other traits that would
compete with Monsanto traits and that would provide benefits to United
States cotton farmers, including other insect-resistant traits,
herbicide-tolerant traits, and potentially other cottonseed traits. As
a result, farmers likely will have fewer choices of, and face higher
prices for, traited cottonseed.
V. Entry
43. Entry into the traited cottonseed business requires the assets
and expertise both to breed high-performing varieties of cottonseed and
to develop or access herbicide-tolerant and insect-resistant traits to
breed into the cottonseed. Each of those steps requires many years and
the investment of tens of millions of dollars.
44. Entry into the traited cottonseed business would not be timely,
likely, or sufficient in its magnitude, character, and scope to deter
or counteract an anticompetitive increase in the price of traited
cottonseed by the merged Monsanto or DPL.
VI. Violation Alleged
45. The effect of Monsanto's merger with DPL may be substantially
to lessen competition in the market for the development, production,
and sale of traited cottonseed in violation of Section 7 of the Clayton
Act. Unless restrained, the transaction would likely have the following
effects, among others:
a. Competition in the market for the development, production, and
sale of traited cottonseed in the MidSouth and Southeast United States
would be substantially lessened; and
b. Cotton farmers will suffer harm as a result of fewer choices and
higher prices for traited cottonseed.
VII. Request for Relief
Plaintiff requests that this Court adjudicate and decree as
follows:
1. That Monsanto's proposed merger with DPL would violate Section 7
of the Clayton Act, as amended, 15 U.S.C. 18;
2. That Monsanto and DPL be permanently enjoined from carrying out
their proposed merger, or from entering into or carrying out any
agreement, understanding, or plan, the effect of which would be to
combine the businesses or assets of Monsanto and DPL;
3. That Plaintiff be awarded the costs of this action; and
4. Such other relief as the Court may deem just and proper.
Dated: May 31, 2007.
Respectfully submitted,
For Plaintiff United States
Thomas O. Barnett,
Assistant Attorney General.
David L. Meyer,
Deputy Assistant Attorney General.
J. Robert Kramer II,
Director of Operations.
Donna N. Kooperstein,
Chief, Transportation, Energy & Agriculture Section.
William H. Stallings,
Assistant Chief, Transportation, Energy & Agriculture Section.
Jill A. Ptacek (WA Bar 18756)
Angela L. Hughes (DC Bar 303420)
J. Richard Doidge (MA Bar 600158)
Michael D. Billiel (DC Bar 394377)
David A. Blotner (WI Bar 1008674)
Ian R. Conner (V A Bar 65349)
John W. Elias (CA Bar 244620)
Tracy L. Fisher (MN Bar 315837)
Mark J. Niefer (DC Bar 470370)
Sarah L. Wagner (TX Bar 24013700)
Trial Attorneys, U.S. Department of Justice, Antitrust Division,
Transportation, Energy & Agriculture Section, 325 7th Street, NW.,
Suite 500, Washington, DC 20004 Telephone: (202) 307-6607,
Facsimile: (202) 307-2784.
Appendix A--Definition of HHI
``HHI'' means the Herfindahl-Hirschman Index, a commonly
accepted measure of market concentration. It is calculated by
squaring the market share of each firm competing in the market and
then summing the resulting numbers. For example, for a market
consisting of four firms with shares of 30, 30, 20, and 20 percent,
the HHI is 2,600 (30\2\ + 30\2\ +20\2\ + 20\2\ = 2,600). (Note:
Throughout the Complaint, market share percentages have been rounded
to the nearest whole number, but HHIs have been estimated using
unrounded percentages in order to accurately reflect the
concentration of the various markets.) The HHI takes into account
the relative size distribution of the firms in a market and
approaches zero when a market consists of a large number of small
firms. The HHI increases both as the number of firms in the market
decreases and as the disparity in size between those firms
increases.
Markets in which the HHI is between 1,000 and 1,800 points are
considered to be moderately concentrated, and those in which the HHI
is in excess of 1,800 points are considered to be highly
concentrated. See Horizontal Merger Guidelines 1.51 (revised Apr. 8,
1997). Transactions that increase the HHI by more than 100 points in
concentrated markets presumptively raise antitrust concerns under
the guidelines issued by the U.S. Department of Justice and Federal
Trade Commission. See id.
United States District Court for the District of Columbia
United States of America, Plaintiff, Monsanto Company and Delta and
Pine Land Company, Defendants.
Case: 1:07-cv-00992 Assigned To: Urbina, Ricardo M. Assign Date: 5/
31/2007 Description: Antitrust.
Proposed Final Judgment
Whereas, Plaintiff United States of America filed its Complaint on
May 31, 2007, Plaintiff and Defendants, Monsanto Company (``Monsanto'')
and Delta and Pine Land Company (``DPL''), by their respective
attorneys, have consented to the entry of this Final Judgment without
trial or adjudication of any issue of fact or law, and without this
Final Judgment constituting any evidence against or admission by any
party regarding any issue of fact or law;
And whereas, Defendants agree to be bound by the provisions of this
Final Judgment pending its approval by the Court;
And whereas, the essence of this Final Judgment is the prompt and
certain divestiture of certain rights and assets and alterations of
certain existing license terms by Defendants to assure that competition
is not substantially lessened;
And whereas, Plaintiff requires Defendants to make certain
divestitures and alter certain existing license terms for the purpose
of remedying the loss of competition alleged in the Complaint;
And whereas, Defendants have represented to Plaintiff that the
divestitures and license term alterations required below can and shall
be made and that Defendants shall later raise no claim of hardship or
difficulty as grounds for asking the Court to modify any of the
divestiture or license alteration provisions contained below;
[[Page 33340]]
Now therefore, before any testimony is taken, without trial or
adjudication of any issue of fact or law, and upon consent of the
parties, it is ordered, adjudged and decreed:
I. Jurisdiction
This Court has jurisdiction over the subject matter of and each of
the parties to this action. The Complaint states a claim upon which
relief may be granted against Defendants under Section 7 of the Clayton
Act, 15 U.S.C. 18.
II. Definitions
As used in this Final Judgment:
A. ``Acquirer of the Enhanced Stoneville Assets'' means the entity
or entities to whom Defendant Monsanto divests the Enhanced Stoneville
Assets.
B. ``Cotton States'' means Defendant Monsanto's cotton variety
licensing business pursuant to which Defendant Monsanto licenses other
cottonseed companies to produce or sell Defendant Monsanto's own cotton
varieties, cotton varieties Defendant Monsanto in-licenses from other
breeders, or cotton varieties Defendant Monsanto produces from such
varieties.
C. ``DPL'' means Defendant Delta and Pine Land Company, a Delaware
corporation with its headquarters in Scott, Mississippi, its successors
and assigns, and its subsidiaries, divisions, groups, affiliates,
interests in partnerships and joint ventures, and their directors,
officers, managers, agents, and employees.
D. ``DPL Acquirer'' means the entity to whom Defendant Monsanto
divests Defendant DPL.
E. ``Monsanto'' means Defendant Monsanto Company, a Delaware
corporation with its headquarters in St. Louis, Missouri, its
successors and assigns, and its subsidiaries, divisions, groups,
affiliates, partnerships and joint ventures, and their directors,
officers, managers, agents, and employees.
F. ``Stoneville'' means all assets used exclusively or primarily
in, or to support, the U.S. business of Stoneville Pedigreed Seed
Company, including, but not limited to the assets described in Schedule
A.
G. ``Enhanced Stoneville Assets'' means Stoneville and the
additional assets, properties, and rights listed in Schedule B.
H. ``Syngenta'' means Syngenta Crop Protection AG, a Swiss
corporation with its headquarters in Basel, Switzerland, its successors
and assigns, and its subsidiaries, divisions, groups, affiliates,
partnerships and joint ventures, and their directors, officers,
managers, agents, and employees.
I. ``Vip Cot Assets'' means the assets, properties, and rights
listed in Schedule C.
III. Applicability
A. This Final Judgment applies to Defendants Monsanto and DPL, as
defined above, and all other persons in active concert or participation
with any of them who receive actual notice of this Final Judgment by
personal service or otherwise.
B. If, prior to complying with Sections IV and V of this Final
Judgment, Defendants sell or otherwise dispose of all or substantially
all of their assets that include the Enhanced Stoneville Assets or the
VipCot Assets, they shall require, as a condition of the sale or other
disposition, that the purchaser(s) agree to be bound by the provisions
of this Final Judgment. Defendants need not obtain such an agreement
from the acquirers of the assets divested pursuant to this Final
Judgment.
IV. Divestiture of Enhanced Stoneville Assets
A. Defendants are ordered and directed, in accordance with the
terms of this Final Judgment, within ninety (90) calendar days after
the filing of the Complaint in this matter, to divest the Enhanced
Stoneville Assets to an acquirer acceptable to Plaintiff in Plaintiff's
sole discretion. Defendants shall use their best efforts to accomplish
the divestiture of the Enhanced Stoneville Assets as expeditiously as
possible. Plaintiff, in its sole discretion, may grant one or more
extensions of this time period, not to exceed sixty (60) calendar days
in total, and shall notify the Court in each such circumstance.
B. Within two (2) business days following execution of a definitive
agreement or agreements for the divestiture of the Enhanced Stoneville
Assets, or the filing of this Final Judgment, whichever is later,
Defendants shall notify Plaintiff in writing of the proposed
divestiture. The notice shall set forth the details of the proposed
divestiture, including a list of the name, address, and telephone
number of each person who offered, or expressed an interest in or
desire, to acquire any ownership interest in the Enhanced Stoneville
Assets, together with full details of the same. Defendants need not
include in this notice information about any persons previously
identified in an affidavit filed in compliance with this Final Judgment
as offering, or expressing an interest in or desiring, to acquire any
ownership interest in the Enhanced Stoneville Assets. Defendants shall
include with the notice a copy of the divestiture agreement or
agreements and copies of any other agreements entered into by either or
both of the Defendants and the proposed Acquirer of the Enhanced
Stoneville Assets since the Complaint in this matter was filed, or up
to three (3) months before the filing of the Complaint in this matter.
Defendants may incorporate by reference in this notice any responsive
information or documents previously provided to Plaintiff, provided
that Defendants identify with specificity when the information or
documents were previously provided and, if the information or documents
were part of a larger submission, where in the submission the
information or documents may be located.
C. Within fifteen (15) calendar days of receipt by Plaintiff of
such notice, Plaintiff may request from Defendants, the proposed
Acquirer of the Enhanced Stoneville Assets, or any other third party,
additional information concerning the proposed divestiture, the
proposed Acquirer of the Enhanced Stoneville Assets, and any other
potential acquirer. Defendants shall furnish any additional information
requested of Defendants within fifteen (15) calendar days of the
receipt of the request, unless Defendants and Plaintiff shall otherwise
agree.
D. Within fifteen (15) calendar days after receipt of the notice or
within ten (10) calendar days after Plaintiff has been provided the
additional information requested from Defendants, the proposed Acquirer
of the Enhanced Stoneville Assets, and any third party, whichever is
later, Plaintiff shall provide written notice to Defendants stating
whether or not it objects to the proposed divestiture. If Plaintiff
provides written notice that it does not object, the divestiture may be
consummated. Absent written notice that Plaintiff does not object to
the proposed Acquirer of the Enhanced Stoneville Assets or upon
objection by Plaintiff, the divestiture of the Enhanced Stoneville
Assets to that proposed Acquirer shall not be consummated.
E. The divestiture of the Enhanced Stoneville Assets shall be
accomplished in such a way as to satisfy Plaintiff, in its sole
discretion, that the Enhanced Stoneville Assets can and shall be used
by the Acquirer of the Enhanced Stoneville Assets to operate a viable,
ongoing business engaged in the development, production and sale of
traited cottonseed. The divestiture of the Enhanced Stoneville Assets:
(1) Shall be made to an Acquirer of the Enhanced Stoneville Assets
that, in Plaintiff's sole judgment, has the intent and capability
(including the necessary
[[Page 33341]]
managerial, operational, technical, and financial capability and
intellectual property rights) of competing effectively in the business
of developing, producing and selling traited cottonseed in the United
States, including a credible commitment to the traited cottonseed
market;
(2) Shall be accomplished so as to satisfy Plaintiff, in its sole
discretion, that the divestiture shall not result in the substantial
lessening of competition for the development, production, and sale of
traited cottonseed in any geographic area; and
(3) Shall be accomplished so as to satisfy Plaintiff, in its sole
discretion, that none of the terms of any agreement between an Acquirer
of the Enhanced Stoneville Assets and Defendants give Defendants the
ability unreasonably to raise the Acquirer's costs, to lower the
Acquirer's efficiency, or otherwise to interfere in the ability of the
Acquirer to compete effectively.
F. Defendants shall provide to the Acquirer of the Enhanced
Stoneville Assets and Plaintiff information relating to the personnel
primarily involved in the operation of Stoneville to enable the
Acquirer of the Enhanced Stoneville Assets to make offers of
employment. Defendants shall not interfere with any negotiations by the
Acquirer of the Enhanced Stoneville Assets to employ any such
personnel.
G. For a period of two (2) years from the filing of the Complaint
in this matter, Defendants shall not solicit to hire, or hire, any
individual primarily involved in the operation of Stoneville on the
date of the filing of the Complaint in this matter who receives a
substantially equivalent offer of employment from the Acquirer, unless
such individual is terminated or laid off by the Acquirer, or the
Acquirer agrees that Defendants may solicit and employ that individual.
H. Defendants shall not take any action that shall impede in any
way the operation, use or divestiture of the Enhanced Stoneville
Assets.
I. Defendants shall warrant to the Acquirer of the Enhanced
Stoneville Assets that there are no material defects in the
environmental, zoning or other permits pertaining to the operation of
each asset that shall have a material adverse effect on the operation
of the Enhanced Stoneville Assets, and that following the sale of the
Enhanced Stoneville Assets, Defendants shall not undertake, directly or
indirectly, any challenges to the environmental, zoning, or other
permits relating to the use or operation of the Enhanced Stoneville
Assets based on actions or inactions that existed prior to the date of
divestiture.
V. Divestiture of VipCot Assets
A. Defendants are ordered and directed, in accordance with the
terms of this Final Judgment, to offer Syngenta the VipCot Assets
listed in the attached Schedule C within thirty (30) calendar days of
the filing of the Complaint in this matter. The offer shall remain open
for at least six (6) months. Defendants shall use their best efforts to
accomplish the divestiture of the VipCot Assets as expeditiously as
possible, but in any event no later than ninety (90) calendar days
after the divestiture of the Enhanced Stoneville Assets or thirty (30)
calendar days after Syngenta accepts the offer, whichever is latest.
Plaintiff, in its sole discretion, may extend the time period for
Defendants to divest the VipCot Assets to Syngenta by granting one or
more extensions, not to exceed ninety (90) calendar days in total, and
shall notify the Court in each such circumstance.
B. Prior to transmitting to Syngenta the offer for the assets
described in the attached Schedule C, Defendants shall provide
Plaintiff with copies of the offer for the approval of the Plaintiff in
its sole discretion. Along with the offer, Defendants shall provide
Plaintiff copies of any other agreements not previously provided to
Plaintiff entered into by either or both of the Defendants and Syngenta
since the Complaint in this matter was filed, or up to three (3) months
before the filing of the Complaint in this matter. Within five (5)
business days following receipt of the offer, Plaintiff shall provide
written notice to Defendants stating whether the offer must be amended
to meet the objectives of the divestiture of the VipCot Assets. Absent
written notice that Plaintiff does not object to the offer, the
divestiture of the VipCot Assets to Syngenta pursuant to the offer
shall not proceed. Upon objection by Plaintiff, Defendants shall alter
the terms of the offer to satisfy Plaintiff in its sole discretion.
C. Defendants shall permit Syngenta to have reasonable access to
personnel and to any and all financial, operational, or other documents
and information relating to the VipCot Assets customarily provided as
part of a due diligence process.
D. Defendants shall not take any action that shall harm the VipCot
Assets or impede in any way the divestiture of the VipCot Assets.
VI. Changes in Third Party Licenses
A. Defendant Monsanto agrees to offer to its licensees, within
thirty (30) calendar days of the date of the sale of the Enhanced
Stoneville Assets, to make the following changes to its third-party
cottonseed trait and Cotton States licenses, subject to the approval of
Plaintiff in its sole discretion:
1. Current Cotton Insect Resistance and Herbicide Tolerance Trait
Licensing--Agreements: Defendant Monsanto shall modify its current
cottonseed trait licenses to provide the licensees with the flexibility
Defendant DPL currently has to develop, market or sell cottonseed
containing non-Monsanto traits by removing any provisions that require
or incentivize the licensee to develop, market or sell cottonseed
containing only traits from Defendant Monsanto.
2. Cotton States Licenses: Defendant Monsanto shall modify its
Cotton--States licenses to eliminate any provision that allows
Defendant Monsanto to terminate the license if the licensee sells
cottonseed containing non-Monsanto traits in brands not licensed under
the Cotton States license.
B. Prior to making the offers, and no later than five (5) days
after the date of sale of the Enhanced Stoneville Assets, Defendant
Monsanto shall provide Plaintiff with copies of the offers for the
approval of Plaintiff in its sole discretion. Within five (5) days of
receipt of the offers to modify the license agreements, Plaintiff shall
provide written notice to Defendant Monsanto stating whether the offers
must be amended. Absent written notice that Plaintiff does not object
to the offers, Defendant Monsanto may not proceed with offering the
modifications to the licensees. Upon objection by Plaintiff, Defendant
Monsanto shall alter the terms of the offers to satisfy Plaintiff in
its sole discretion. In the event any of the licensees do not accept
the offer containing the modifications described in Section VI.A. as
approved by Plaintiff in its sole discretion, Defendant Monsanto shall
act as though such modification has been made and shall not enforce any
license provision that is the subject of any such modification.
VII. Divestiture of Defendant DPL
A. If Defendants have not divested the Enhanced Stoneville Assets
by the end of the time period permitted by this Final Judgment,
Defendants shall notify Plaintiff of that fact in writing. Defendant
Monsanto shall then divest DPL within sixty (60) days. If Defendant
Monsanto has not divested Defendant DPL by the end of the sixty-day
period, Defendant Monsanto shall notify Plaintiff of that fact in
writing. Upon application of Plaintiff, the Court shall appoint a
trustee selected by Plaintiff and approved by the Court to effect the
divestiture of Defendant DPL.
[[Page 33342]]
B. Defendant Monsanto shall use its best efforts to assist the
trustee in accomplishing the required divestiture of Defendant DPL,
including its best efforts to effect all necessary regulatory
approvals. The trustee and any consultants, accountants, attorneys, and
other persons retained by the trustee shall have full and complete
access to the personnel, books, records, and assets at the facilities
to be divested, and Defendant Monsanto shall develop financial or other
information relevant to the assets to be divested customarily provided
in a due diligence process as the trustee may reasonably request,
subject to reasonable protection for confidential commercial
information. In addition, Defendant Monsanto shall:
(1) Permit prospective acquirers of Defendant DPL who have been
invited to submit binding bids for Defendant DPL to have reasonable
access to Defendant DPL's personnel and to make such inspection of
Defendant DPL and any and all financial, operational, or other
documents and other information as may be relevant to the divestiture
of Defendant DPL, subject to reasonable protection for confidential
commercial information;
(2) Provide the DPL Acquirer and Plaintiff information relating to
the personnel of Defendant DPL to enable the DPL Acquirer to make
offers of employment;
(3) Take no action to interfere with any negotiations by the DPL
Acquirer to employ any Defendant DPL employee;
(4) Take no action to interfere with or to impede the trustee's
accomplishment of the divestiture of Defendant DPL;
(5) Warrant to the DPL Acquirer that on the date of sale each asset
shall be in the same condition as when Defendant Monsanto acquired
Defendant DPL, except for the harvesting of cotton plants and selection
lines in the ordinary course of business, and ordinary wear and tear of
assets and facilities;
(6) Warrant to the DPL Acquirer that there are no material defects
in the environmental, zoning or other permits pertaining to the
operation of each asset that have arisen since Defendant Monsanto
acquired Defendant DPL; and
(7) Shall not, following divestiture of Defendant DPL, undertake,
directly or indirectly, any challenges to the environmental, zoning, or
other permits relating to the operation of Defendant DPL, or otherwise
take any action that shall impede in any way the permitting, operation,
or divestiture of Defendant DPL.
C. Unless Plaintiff otherwise consents in writing, the divestiture
of Defendant DPL pursuant to this Section of the Final Judgment,
whether accomplished by Defendant Monsanto or a trustee, shall include
the entirety of Defendant DPL, and shall be accomplished in such a way
as to satisfy Plaintiff, in its sole discretion, that (a) Defendant DPL
shall remain no less viable than when Defendant Monsanto acquired it,
(b) the divestiture of Defendant DPL shall remedy the competitive harm
alleged in the Complaint, and (c) none of the terms of any agreement
between a DPL Acquirer and Defendant Monsanto give Defendant Monsanto
the ability unreasonably to raise that person's costs, to lower that
person's efficiency, or otherwise to interfere in the ability of that
person to compete effectively.
D. The trustee shall have the power and authority to accomplish the
divestiture of Defendant DPL at the earliest possible time to an
acquirer acceptable to Plaintiff, in its sole discretion, at such price
and on such terms as are then obtainable upon reasonable effort by the
trustee, and shall have such other powers as the Court deems
appropriate. Subject to Section VII.F of this Final Judgment, the
trustee shall have the power and authority to hire at the cost and
expense of Defendant Monsanto any investment bankers, attorneys, or
other agents who are reasonably necessary in the judgment of the
trustee to assist in the divestiture of Defendant DPL and who shall be
solely accountable to the trustee.
E. Defendant Monsanto shall not object to a sale by the trustee on
any ground other than the trustee's malfeasance. Any such objections by
Defendant Monsanto must be conveyed in writing to Plaintiff and the
trustee within ten (10) calendar days after the trustee has provided
the notice required under this Section.
F. The trustee shall serve at the cost and expense of Defendant
Monsanto, on such terms and conditions as Plaintiff approves, and shall
account for all monies derived from the sale of the assets sold by the
trustee and all costs and expenses so incurred. After approval by the
Court of the trustee's accounting, including fees for its services and
those of any professionals and agents retained by the trustee, all
remaining money shall be paid to Defendant Monsanto, and the trust
shall then be terminated. The compensation of the trustee and of any
professionals and agents retained by the trustee shall be reasonable in
light of the value of Defendant DPL and based on a fee arrangement
providing the trustee with an incentive based on the price and terms of
the divestiture of Defendant DPL and the speed with which it is
accomplished, but timeliness is paramount.
G. After its appointment, the trustee shall file monthly reports
with Plaintiff, Defendant Monsanto, and the Court setting forth the
trustee's efforts to accomplish the divestiture of Defendant DPL,
provided however, that to the extent such reports contain information
that the trustee deems confidential, such reports shall not be filed in
the public docket of the Court and Defendant Monsanto's copy of the
report shall have such confidential information redacted. Such reports
shall include the name, address, and telephone number of each person
who, during the preceding month, made an offer to acquire, expressed an
interest in acquiring, entered into negotiations to acquire, or was
contacted or made an inquiry about acquiring, any interest in Defendant
DPL, and shall describe in detail each contact with any such person
during that period. The trustee shall maintain full records of all
efforts made to divest Defendant DPL.
H. If the trustee has not accomplished such divestiture of
Defendant DPL within ninety (90) calendar days after its appointment,
the trustee shall file promptly with the Court a report setting forth
(1) The trustee's efforts to accomplish the required divestiture of
Defendant DPL; (2) the reasons, in the trustee's judgment, why the
required divestiture of Defendant DPL has not been accomplished; and
(3) the trustee's recommendations. To the extent such report contains
information that the trustee deems confidential, such report shall not
be filed in the public docket of the Court. The trustee shall at the
same time furnish such report to Plaintiff. Plaintiff shall have the
right to make additional recommendations consistent with the purpose of
the trust. The Court shall enter thereafter such orders as it shall
deem appropriate to carry out the purpose of this Final Judgment which
may, if necessary, include extending this Final Judgment and the term
of the trustee's appointment by a period requested by Plaintiff.
I. The trustee shall notify Plaintiff and Defendant Monsanto within
two (2) business days following execution of a definitive agreement for
the sale of Defendant DPL. The notice shall set forth the details of
the proposed divestiture of Defendant DPL and list the name, address,
and telephone number of each person not previously identified who
offered or expressed an interest in or desire to acquire any ownership
interest in Defendant DPL, together with full details of the same.
[[Page 33343]]
J. Within fifteen (15) calendar days of receipt by Plaintiff of
such notice, Plaintiff may request from Defendants, the proposed DPL
Acquirer, any other third party, or the trustee, additional information
concerning the proposed divestiture of Defendant DPL, the proposed DPL
Acquirer, and any other potential acquirer. Defendants and the trustee
shall furnish any additional information requested within fifteen (15)
calendar days of the receipt of the request, unless the Defendants and
Plaintiff shall otherwise agree.
K. Within thirty (30) calendar days after receipt of the notice or
within twenty (20) calendar days after Plaintiff has been provided the
additional information requested from Defendant Monsanto, the proposed
DPL Acquirer, any third party, and the trustee, whichever is later,
Plaintiff shall provide written notice to Defendant Monsanto and the
trustee stating whether or not it objects to the proposed divestiture
of Defendant DPL. If Plaintiff provides written notice that it does not
object, the sale of Defendant DPL may be consummated, subject only to
Defendant Monsanto's limited right to object to the sale under Section
VII.E of this Final Judgment. Absent written notice that Plaintiff does
not object to the proposed DPL Acquirer or upon objection by Plaintiff,
the sale of Defendant DPL shall not be consummated. Upon objection by
Defendant Monsanto under Section VII.E, a sale of Defendant DPL
proposed under this Section shall not be consummated unless approved by
the Court.
VIII. Financing
Defendants shall not finance all or any part of any purchase made
pursuant to Section IV or Section VII of this Final Judgment.
IX. Hold Separate
Until the divestitures required by this Final Judgment have been
accomplished, Defendants shall take all steps necessary to comply with
the Hold Separate and Preservation of Assets Stipulation and Order
entered by this Court. Defendants shall take no action that would
jeopardize the divestitures ordered by this Court.
X. Affidavits
A. Within ten (10) calendar days of the filing of the Complaint in
this matter, and every thirty (30) calendar days thereafter until the
divestitures have been completed under Sections IV and V, Defendants
shall deliver to Plaintiff an affidavit as to the fact and manner of
its compliance with Sections IV, V, and VI of this Final Judgment. Each
such affidavit shall include the name, address, and telephone number of
each person who, during the preceding thirty days, made an offer to
acquire, expressed an interest in acquiring, entered into negotiations
to acquire, or was contacted or made an inquiry about acquiring, any
interest in the Enhanced Stoneville Assets, and shall describe in
detail each contact with any such person during that period, including
a summary of all conversations (1) Between Defendants and any Acquirer
of the Enhanced Stoneville Assets, and (2) between Defendants and
Syngenta with respect to the VipCot Assets. Defendants may incorporate
by reference in any such affidavit any responsive information or
documents previously provided to Plaintiff, provided however, that
Defendants identify with specificity when the information or documents
were previously provided and, if the information or documents were part
of a larger submission, where in the submission the information or
documents may be located. Assuming the information set forth in the
affidavit is true and complete, any objection by Plaintiff to
information provided by Defendants, including any limitation on
information, shall be made within fourteen (14) days of receipt of such
affidavit.
B. Defendants shall keep all records of all efforts made to
preserve and divest the Enhanced Stoneville Assets and VipCot Assets
until one year after each such divestiture has been completed.
XI. Compliance Inspection
A. For the purposes of determining or securing compliance with this
Final Judgment, or of determining whether the Final Judgment should be
modified or vacated, and subject to any legally recognized privilege,
from time to time duly authorized representatives of the United States
Department of Justice, including consultants and other persons retained
by the United States, shall, upon written request of a duly authorized
representative of the Assistant Attorney General in charge of the
Antitrust Division, and on reasonable notice to Defendants, be
permitted:
(1) Access during Defendants' office hours to inspect and copy, or
at Plaintiffs option, to require Defendants to provide copies of all
books, ledgers, accounts, records and documents in the possession,
custody, or control of Defendants, relating to any matters contained in
this Final Judgment; and
(2) To interview, either informally or on the record, Defendants'
officers, employees, or agents, who may have their individual counsel
present, regarding such matters. The interviews shall be subject to the
reasonable convenience of the interviewee and without restraint or
interference by Defendants.
B. Upon the written request of a duly authorized representative of
the Assistant Attorney General in charge of the Antitrust Division,
Defendants shall submit written reports or responses to written
interrogatories, under oath if requested, relating to any of the
matters contained in this Final Judgment as may be requested.
C. No information or documents obtained by the means provided in
this Section shall be divulged by Plaintiff to any person other than an
authorized representative of the executive branch of the United States,
except in the course of legal proceedings to which the United States is
a party (including grand jury proceedings), or for the purpose of
securing compliance with this Final Judgment, or as otherwise required
by law.
D. If, at the time information or documents are furnished by
Defendants to Plaintiff, Defendants represent and identify in writing
the material in any such information or documents to which a claim of
protection may be asserted under Rule 26(c)(7) of the Federal Rules of
Civil Procedure, and Defendants mark each pertinent page of such
material, ``Subject to claim of protection under Rule 26( c)(7) of the
Federal Rules of Civil Procedure,'' then Plaintiff shall give
Defendants ten (10) calendar days' notice prior to divulging such
material in any legal proceeding (other than a grand jury proceeding).
XII. Notification
A. Unless such transaction is otherwise subject to the reporting
and waiting period requirements of the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended, 15 U.S.C. 18a (the ``HSR Act''),
Defendant Monsanto, without providing advance notification to
Plaintiff, shall not directly or indirectly acquire (1) Voting
securities, (2) all or substantially all of the cotton germplasm, or
(3) substantially all of the assets relating to cottonseeds or
cottonseed traits, of any company that develops and sells cottonseed in
the United States, or any company that has developed, or has under
development traits for commercialization in cottonseed in the United
States, where such acquisition would be reportable under the HSR Act
but for a failure to satisfy the thresholds of 15 U.S.C. l8a(a)(2).
[[Page 33344]]
B. Such notification shall be provided to Plaintiff in the same
format as, and per the instructions relating to the Notification and
Report Form set forth in the Appendix to Part 803 of Title 16 of the
Code of Federal Regulations as amended, except that the information
requested in Items 5 through 9 of the instructions must be provided
only about cottonseeds or transgenic traits that shall be or could be
used in cottonseeds. Notification shall be provided at least thirty
(30) days prior to acquiring any such interest, and shall include,
beyond what may be required by the applicable instructions, the names
of the principal representatives of the parties to the agreement who
negotiated the agreement, and any management or strategic plans
discussing the proposed transaction. If within the thirty (30) day
period after notification, representatives of Plaintiff make a written
request for additional information, Defendant Monsanto shall not
consummate the proposed transaction or agreement until twenty (20) days
after submitting all such additional information. Early termination of
the waiting periods in this paragraph may be requested and, where
appropriate, granted in the same manner as is applicable under the
requirements and provisions of the HSR Act and rules promulgated
thereunder. This Section shall be broadly construed and any ambiguity
or uncertainty regarding the filing of notice under this Section shall
be resolved in favor of filing notice.
XIII. No Reacquisition
If Defendant Monsanto divests the Enhanced Stoneville Assets and
the VipCot Assets, Defendant Monsanto may not reacquire any part of the
Enhanced Stoneville Assets or the VipCot Assets during the term of this
Final Judgment. If Defendant Monsanto divests Defendant DPL, it may not
reacquire any part of Defendant DPL during the term of this Final
Judgment.
XIV. Retention of Jurisdiction
This Court retains jurisdiction to enable any party to this Final
Judgment to apply to this Court at any time for further orders and
directions as may be necessary or appropriate to carry out or construe
this Final Judgment, to modify any of its provisions, to enforce
compliance, and to punish violations of its provisions.
XV. Expiration of Final Judgment
Unless this Court grants an extension, this Final Judgment shall
expire ten (10) years from the date of its entry.
XVI. Public Interest Determination
Entry of this Final Judgment is in the public interest. The parties
have complied with the requirements of the Antitrust Procedures and
Penalties Act, 15 U.S.C. 16, including making copies available to the
public of this Final Judgment, the Competitive Impact Statement, and
any comments thereon and Plaintiff's responses to comments. Based upon
the record before the Court, which includes the Competitive Impact
Statement and any comments and response to comments filed with the
Court, entry of this Final Judgment is in the public interest.
Date:------------------------------------------------------------------
Court approval subject to procedures of Antitrust Procedures and
Penalties Act, 15 U.S.C. 16.
-----------------------------------------------------------------------
United States District Judge
Definitions for Schedules
1. ``Advanced Exotic Yield Lines'' means the Breeding populations
and proprietary Lines created by Defendant Monsanto from a cross
between Gossypium hirsutum and Gossypium barbadense that are identified
in Schedule D.
2. ``Backcross'' means to cross a hybrid with one of its parents
and then to cross the resulting progeny with the same parent Line
(perhaps multiple times) in order to develop progeny with a genetic
makeup that approximates the genetic make up of that parent while
retaining certain desirable characteristics of the genetic makeup of
the other parent of the hybrid.
3. ``Breed'' means to purposefully modify the Germplasm of a plant
so as to alter its genetic make up, and to develop the progeny from the
altered Germplasm.
4. ``DPL Marker Data'' means Fingerprints that Defendant Monsanto
shall create for the DPL Germplasm being divested pursuant to Schedule
B.2.
5. ``Donor Lines'' means the cotton Lines used by Defendant
Monsanto to create or transmit novel cotton traits or events, and
identified in Schedule F.
6. ``Fingerprint'' means a record of the presence or absence of
genetic markers for which a Line has been tested.
7. ``Germplasm'' means a collection of heterozygous and homozygous
cotton plants or parts thereof. For purposes of Schedules B and C of
this Final Judgment, when the Defendants are required to convey
Germplasm to a party, the Defendant may satisfy that obligation by
conveying that Germplasm in seed form, or if necessary, in potted plant
form.
8. ``Introgress'' means to move a gene from one cotton plant into
another.
9. ``Line'' means a set of cottonseed or plants that share a common
reasonably homogenous genotype that originate from a cross between two
cotton plants.
10. ``MAB Populations'' means the Germplasm populations for which
Defendant Monsanto has conducted significant marker analyses that are
identifie